A premalignant change arising in the prostatic epithelium, regarded as the most important and most likely precursor of prostatic adenocarcinoma. The neoplasia takes the form of an intra-acinar or ductal proliferation of secretory cells with unequivocal nuclear anaplasia, which corresponds to nuclear grade 2 and 3 invasive prostate cancer.
Tumors or cancer of the PROSTATE.
A gland in males that surrounds the neck of the URINARY BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM.
A malignancy arising in uterine cervical epithelium and confined thereto, representing a continuum of histological changes ranging from well-differentiated CIN 1 (formerly, mild dysplasia) to severe dysplasia/carcinoma in situ, CIN 3. The lesion arises at the squamocolumnar cell junction at the transformation zone of the endocervical canal, with a variable tendency to develop invasive epidermoid carcinoma, a tendency that is enhanced by concomitant human papillomaviral infection. (Segen, Dictionary of Modern Medicine, 1992)
Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.
Tumors or cancer of the UTERINE CERVIX.
A malignant epithelial tumor with a glandular organization.
Pathological processes that tend eventually to become malignant. (From Dorland, 27th ed)
Enzymes that catalyze inversion of the configuration around an asymmetric carbon in a substrate having one (racemase) or more (epimerase) center(s) of asymmetry. (Dorland, 28th ed) EC 5.1.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
Complete or partial surgical removal of the prostate. Three primary approaches are commonly employed: suprapubic - removal through an incision above the pubis and through the urinary bladder; retropubic - as for suprapubic but without entering the urinary bladder; and transurethral (TRANSURETHRAL RESECTION OF PROSTATE).
Neoplasms of the skin and mucous membranes caused by papillomaviruses. They are usually benign but some have a high risk for malignant progression.
Tumors or cancer of the VULVA.
The examination, therapy or surgery of the cervix and vagina by means of a specially designed endoscope introduced vaginally.
A family of small, non-enveloped DNA viruses infecting birds and most mammals, especially humans. They are grouped into multiple genera, but the viruses are highly host-species specific and tissue-restricted. They are commonly divided into hundreds of papillomavirus "types", each with specific gene function and gene control regions, despite sequence homology. Human papillomaviruses are found in the genera ALPHAPAPILLOMAVIRUS; BETAPAPILLOMAVIRUS; GAMMAPAPILLOMAVIRUS; and MUPAPILLOMAVIRUS.
A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer.
Methods which attempt to express in replicable terms the level of CELL DIFFERENTIATION in neoplasms as increasing ANAPLASIA correlates with the aggressiveness of the neoplasm.
Infiltration of inflammatory cells into the parenchyma of PROSTATE. The subtypes are classified by their varied laboratory analysis, clinical presentation and response to treatment.
Removal and examination of tissue obtained through a transdermal needle inserted into the specific region, organ, or tissue being analyzed.
Collection of pooled secretions of the posterior vaginal fornix for cytologic examination.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.
A lipid phosphatase that acts on phosphatidylinositol-3,4,5-trisphosphate to regulate various SIGNAL TRANSDUCTION PATHWAYS. It modulates CELL GROWTH PROCESSES; CELL MIGRATION; and APOPTOSIS. Mutations in PTEN are associated with COWDEN DISEASE and PROTEUS SYNDROME as well as NEOPLASTIC CELL TRANSFORMATION.
The neck portion of the UTERUS between the lower isthmus and the VAGINA forming the cervical canal.
Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.
Pathological processes involving the PROSTATE or its component tissues.
Tumors or cancer of the VAGINA.
Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or body fluids. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including hormones, antigens, amino and nucleic acids, enzymes, polyamines, and specific cell membrane proteins and lipids.
A glutathione transferase that catalyzes the conjugation of electrophilic substrates to GLUTATHIONE. This enzyme has been shown to provide cellular protection against redox-mediated damage by FREE RADICALS.
Infections produced by oncogenic viruses. The infections caused by DNA viruses are less numerous but more diverse than those caused by the RNA oncogenic viruses.
Abnormal development of immature squamous EPITHELIAL CELLS of the UTERINE CERVIX, a term used to describe premalignant cytological changes in the cervical EPITHELIUM. These atypical cells do not penetrate the epithelial BASEMENT MEMBRANE.
Tumors or cancer of the ANAL CANAL.
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue.
Division of tissues by a high-frequency current applied locally with a metal instrument or needle. (Stedman, 25th ed)
Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA.
Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens.
One or more layers of EPITHELIAL CELLS, supported by the basal lamina, which covers the inner or outer surfaces of the body.
Ability of neoplasms to infiltrate and actively destroy surrounding tissue.
Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells.
Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
Cytological preparation of cells collected from a mucosal surface and stained with Papanicolaou stain.
The simultaneous analysis of multiple samples of TISSUES or CELLS from BIOPSY or in vitro culture that have been arranged in an array format on slides or microchips.
Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
A type of ALPHAPAPILLOMAVIRUS especially associated with malignant tumors of the CERVIX and the RESPIRATORY MUCOSA.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
The excision of a cone of tissue, especially of the CERVIX UTERI.
A class of fibrous proteins or scleroproteins that represents the principal constituent of EPIDERMIS; HAIR; NAILS; horny tissues, and the organic matrix of tooth ENAMEL. Two major conformational groups have been characterized, alpha-keratin, whose peptide backbone forms a coiled-coil alpha helical structure consisting of TYPE I KERATIN and a TYPE II KERATIN, and beta-keratin, whose backbone forms a zigzag or pleated sheet structure. alpha-Keratins have been classified into at least 20 subtypes. In addition multiple isoforms of subtypes have been found which may be due to GENE DUPLICATION.
A technique that localizes specific nucleic acid sequences within intact chromosomes, eukaryotic cells, or bacterial cells through the use of specific nucleic acid-labeled probes.
A type of human papillomavirus especially associated with malignant tumors of the genital and RESPIRATORY MUCOSA.
Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.
A genus of DNA viruses in the family PAPILLOMAVIRIDAE. They preferentially infect the anogenital and ORAL MUCOSA in humans and primates, causing both malignant and benign neoplasms. Cutaneous lesions are also seen.
A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm but is often wrongly used as a synonym for "cancer." (From Dorland, 27th ed)
Genes that are introduced into an organism using GENE TRANSFER TECHNIQUES.
Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm.
Deoxyribonucleic acid that makes up the genetic material of viruses.
Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.
Neoplasms of the SQUAMOUS EPITHELIAL CELLS. The concept does not refer to neoplasms located in tissue composed of squamous elements.
Sexually transmitted form of anogenital warty growth caused by the human papillomaviruses.
All of the processes involved in increasing CELL NUMBER including CELL DIVISION.
A cell line derived from cultured tumor cells.
A transferase that catalyzes the addition of aliphatic, aromatic, or heterocyclic FREE RADICALS as well as EPOXIDES and arene oxides to GLUTATHIONE. Addition takes place at the SULFUR. It also catalyzes the reduction of polyol nitrate by glutathione to polyol and nitrite.
Proteins that are normally involved in holding cellular growth in check. Deficiencies or abnormalities in these proteins may lead to unregulated cell growth and tumor development.
A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
Inbred C57BL mice are a strain of laboratory mice that have been produced by many generations of brother-sister matings, resulting in a high degree of genetic uniformity and homozygosity, making them widely used for biomedical research, including studies on genetics, immunology, cancer, and neuroscience.
Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.
Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins.
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
Proteins encoded by homeobox genes (GENES, HOMEOBOX) that exhibit structural similarity to certain prokaryotic and eukaryotic DNA-binding proteins. Homeodomain proteins are involved in the control of gene expression during morphogenesis and development (GENE EXPRESSION REGULATION, DEVELOPMENTAL).
A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols.
Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.
Disappearance of a neoplasm or neoplastic state without the intervention of therapy.
The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION.
The determination of the pattern of genes expressed at the level of GENETIC TRANSCRIPTION, under specific circumstances or in a specific cell.

Malignant transformation of human prostatic epithelium is associated with the loss of androgen receptor immunoreactivity in the surrounding stroma. (1/308)

The cellular pathways involved in the pathogenesis of hormone resistance remain unclear. Studies evaluating the role of changes in human androgen receptor (hAR) expression in the progression of prostatic tumors have been inconclusive. Androgenic influence over prostatic growth is mediated via the regulation of interactions between stromal and epithelial cells. We hypothesized that neoplastic transformation of the prostate would be associated with alterations in hAR expression in the adjacent stroma. Using immunohistochemical techniques, we determined hAR positivity in the epithelium and adjacent stroma of sections from 17 benign and 39 malignant prostatic glands. We found that whereas the expression of the receptor decreased in both cellular compartments as the tissues dedifferentiated, the depletion was more pronounced in the stromal nuclei (P<0.0001). However, in sections from both untreated and hormone-resistant prostate cancer tissues, although heterogeneity of hAR expression in malignant epithelia was increased, there appeared to be a unique field effect around the cancerous prostate glands that resulted in a decreased expression of the receptor in the adjacent benign glands and its total loss in the surrounding stroma. The loss of hAR in the stroma adjacent to malignant prostatic epithelium may play an important role in prostate cancer progression. Furthermore, the similarity of the lack of stromal hAR expression in newly diagnosed and hormone-resistant prostate cancer (P = 0.85) may be an indication that the mechanisms responsible for the acquisition of hormone independence are established early in the malignant transformation process.  (+info)

De novo expression of CD44 in prostate carcinoma is correlated with systemic dissemination of prostate cancer. (2/308)

AIMS: To evaluate the role of CD44 in early steps in the development of prostate cancer, and to assess the biological significance of preneoplastic lesions in prostate cancer. METHODS: 38 patients with clinically localised prostate cancer were studied. The standard form of CD44 (CD44H) and v6 isoform expressions were semiquantitatively evaluated on paraffin embedded tumour tissue by immunohistochemistry. Disseminated prostatic cells were detected by prostate specific membrane antigen reverse transcriptase polymerase chain reaction in the blood of each patient before radical prostatectomy. RESULTS: In normal or benign prostate glands, only basal cells showed CD44H and v6 labelling. Fourteen of the 38 prostate cancers (37%) had CD44H membranous staining of prostatic tumour cells. In 18 patients (47%), circulating prostatic cells were detected in blood before surgery. Although no correlation between the expression of CD44 and the Gleason score or staging was observed, a significant correlation was found between the expression of CD44H by tumour cells and prostatic cell blood dissemination (p = 0.04). In 28 cases, foci of prostatic intraepithelial neoplasia were observed, and nine had CD44H immunostaining. CONCLUSIONS: De novo expression of CD44 by prostatic tumour cells is associated with systemic dissemination of prostate cells independently of pathological criteria.  (+info)

Does screening for prostate cancer identify clinically important disease? (3/308)

In this study the combination of digital rectal examination (DRE) and serum prostate-specific antigen (PSA) is shown to be effective for detecting early prostate cancer in a urological out-patient setting. PSA provides the means to detect cancer in men with normal DRE that may otherwise present as so-called incidental cancer at transurethral resection of the prostate (TURP) for apparently benign disease or later in the course of its natural history as locally advanced or metastatic disease. PSA progression in men with incidental cancer has been previously demonstrated to be predicted more reliably by residual cancer on needle biopsy after TURP than by tumour in the resected specimen and, therefore re-staging such patients is worthwhile when further treatment would be considered. Among men selected for radical prostatectomy, non-palpable tumours detected with PSA more predictable in pathological extent than incidental cancer and their particular pathological characteristics suggest they include clinically significant tumours that would progress if untreated to palpable and eventually metastatic disease. In view of this progressive behaviour, cancer detected by PSA should be considered clinically significant particularly in men with a life expectancy of at least 10 years. Therefore screening should be offered for such individuals, to detect and treat tumours at a curable stage and thereby eliminate the high mortality and often protracted morbidity commonly associated with metastatic disease.  (+info)

Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia. (4/308)

Membrane type 1-matrix metalloproteinase (MT1-MMP) is a known activator of latent MMP-2 (pro-MMP-2), and increased MMP-2 expression has been associated with tumor aggressiveness in prostate cancer. However, expression of MT1-MMP in human prostate tissue has not been described. We investigated the expression and immunolocalization of MT1-MMP and MMP-2 in the epithelial components of benign prostate epithelium, high-grade prostatic intraepithelial neoplasia (HGPIN), and prostate cancer. Tissue sections from the peripheral zone of 50 prostates (radical prostatectomy specimens) were chosen based on their containing benign glands, HGPIN, and prostate cancer glands. All 50 sections were immunostained for MT1-MMP and MMP-2 and were evaluated for staining pattern, uniformity, and intensity. Western blotting and gelatin zymography were done to confirm expression of MT1-MMP and activity of MMP-2, respectively. Comparisons were made between benign epithelium, HGPIN, and cancer. In benign glands, basal cells (BCs) uniformly stained intensely for MT1-MMP, whereas secretory cells (SCs) were rarely positive (P < 0.0001). Conversely in HGPIN, SCs showed consistent cytoplasmic staining (P < 0.0001). In cancer cells, staining was heterogeneous and varied from no staining to very intense staining in select glands. MMP-2 in normal tissue stained both BCs and the apical region of SCs, whereas in HGPIN, staining was observed in the SC in a predominantly cytoplasmic pattern. Similar to MT1-MMP, staining in cancer tissue for MMP-2 was heterogeneous; however, there was a significant association between the pattern of MMP-2 and MT1-MMP staining within the epithelial components of the cancer glands in individual specimens (P < 0.001). Finally, MMP-2 and MT1-MMP were confirmed to be expressed in the prostate tissues by gelatin zymography and Western blotting. In conclusion, we found that consistent changes in localization and intracellular distribution of MMP-2 and MT1-MMP were associated with the transition from benign prostate epithelium to HGPIN, suggesting that regulation of these enzymes is altered during the earliest stages of prostate cancer.  (+info)

Expression of pi-class glutathione S-transferase: two populations of high grade prostatic intraepithelial neoplasia with different relations to carcinoma. (5/308)

BACKGROUND/AIMS: Patients with high grade prostatic intraepithelial neoplasia of the transition zone appear to be at increased risk of developing prostatic carcinoma, although not to the same degree as patients with high grade prostatic intraepithelial neoplasia of the peripheral/central zone. Previous investigations have shown loss of expression of pi-class glutathione S-transferase (GST-pi; an enzyme that protects against electrophilic carcinogens) in prostatic carcinoma and in high grade prostatic intraepithelial neoplasia. The aim of this study was to compare the expression of GST-pi in high grade prostatic intraepithelial neoplasia of the transition zone with that in high grade prostatic intraepithelial neoplasia of the peripheral/central zone (that is, non-transition zone). METHODS: Immunostaining with the anti-GST-pi antibody was performed on 20 high grade prostatic intraepithelial neoplasia samples of the transition zone, either isolated or associated with prostatic carcinoma (groups 1 and 2, respectively; 10 cases each) and on 20 high grade prostatic intraepithelial neoplasia samples of the non-transition zone, either isolated or associated with prostatic carcinoma (groups 3 and 4, respectively; 10 cases each). This study also included six samples of high grade prostatic intraepithelial neoplasia simultaneously present in the transition and non-transition zones and not associated with prostatic carcinoma (group 5). The presence of immunostaining, staining intensity, and the distribution of immunostaining were evaluated in the high grade prostatic intraepithelial neoplasia lesions and in the normal tissue and cancer areas. RESULTS: The GST-pi antibody stained the cytoplasm of the cells lining the ducts and acini of normal prostate tissue. Staining was stronger and more diffuse in the basal cell layer than in the luminal (or secretory) cell layer. Immunohistochemical staining with anti-GST-pi antibodies failed to detect the enzyme in all prostatic carcinoma foci but one. Two patterns were detected in high grade prostatic intraepithelial neoplasia. One was represented by GST-pi staining similar to that of the normal tissue (pattern A). The other deviated from it and was characterised by absence of GST-pi expression in the secretory cells and abundant expression in scattered basal cells (pattern B). Pattern A staining was seen more frequently in the transition than in the non-transition zone. Pattern B staining was seen mainly in high grade prostatic intraepithelial neoplasia of non-transition zone associated with cancer. CONCLUSIONS: The differential expression of GST-pi in the transition and non-transition zones indicates the existence of two populations with the morphological appearance of high grade prostatic intraepithelial neoplasia that might have different associations with carcinoma.  (+info)

Improving diagnostic accuracy of prostate carcinoma by systematic random map-biopsy. (6/308)

Systematic random rectal ultrasound directed map-biopsy of the prostate was performed in 77 RDE (rectal digital examination) positive and 25 RDE negative cases, if applicable. Hypoechoic areas were found in 30% of RDE positive and in 16% of RDE negative cases. The score for carcinoma in the hypoechoic areas was 6.5% in RDE positive and 0% in RDE negative cases, whereas systematic map biopsy detected 62% carcinomas in RDE positive, and 16% carcinomas in RDE negative patients. The probability of positive diagnosis of prostate carcinoma increased in parallel with the number of biopsy samples/case. The importance of systematic map biopsy is emphasized.  (+info)

Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model. (7/308)

Although the etiology of prostate cancer is still not clear, family history, hormones, and age are thought to play a role in its initiation and progression. There is no cure for the advanced disease. Because prostate cancer initially develops as an androgen-dependent tumor, agents with antiandrogen activity have become the focus for chemoprevention of this disease. A pilot study was undertaken to test the efficacy of flutamide (an antiandrogen) in the transgenic adenocarcinoma of the mouse prostate (TRAMP) model of prostate cancer. Three groups of mice received s.c. implantation of slow-release flutamide pellets: (a) low-dose flutamide group (6.6 mg/kg); (b) high-dose flutamide group (33 mg/kg); and (c) control placebo group. Efficacy was measured by the absence of palpable tumor formation. Prostate tissues/tumors were harvested for evaluation by molecular and histology techniques. The low-dose flutamide group did not differ significantly from the placebo group, in which palpable tumors initially presented at 17 weeks of age, and by 33 weeks, all of the animals developed palpable tumors. In the high-dose flutamide group, however, tumors did not appear until 24 weeks, a lag of 7 weeks, and by 34 weeks, 42% of the animals were still tumor free. The period of time at which 50% of the animals had tumors was 33 weeks in the high-dose flutamide group, 24.5 weeks in the low-dose flutamide group, and 24.5 weeks in the placebo group. The difference between the placebo and high-dose flutamide groups was statistically significant (log rank, P = 0.0036; Wilcoxon's statistical analysis, P = 0.0060). Tumors from high-dose flutamide-treated animals were more differentiated and retained much of the normal glandular architecture compared with those of the placebo group, whose tumors consisted of sheets of poorly differentiated cells. The expression of T antigen in the prostate tissues of flutamide-treated animals (at 10 weeks age) was lower than that in the comparable placebo-treated group. Flutamide had the ability to suppress T antigen-driven carcinogenesis, resulting in a significant decrease in the incidence of prostate cancer and an increase in the latency period of prostate cancer in TRAMP mice.  (+info)

Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer. (8/308)

Fibroblast growth factors (FGFs) are known to play an important role in the growth of normal prostatic epithelial cells. In addition to their effects on proliferation, FGFs can promote cell motility, increase tumor angiogenesis, and inhibit apoptosis, all of which play an important role in tumor progression. To determine whether FGFs are overexpressed in human prostate cancers, we analyzed 26 prostate cancer RNAs by reverse transcription-PCR for expression of FGF3, FGF4, and FGF6, which cannot be detected in normal prostate tissue by this technique. Fourteen of 26 prostate cancers expressed FGF6 mRNA. No expression of FGF3 or FGF4 was detected. An ELISA of tissue extracts of normal prostate, high-grade prostatic intraepithelial neoplasia (PIN), and prostate cancer for FGF6 showed that this growth factor was undetectable in normal prostate but was present at elevated levels in 4 of 9 PIN lesions and in 15 of 24 prostate cancers. Immunohistochemical analysis with anti-FGF6 antibody revealed weak staining of prostatic basal cells in normal prostate that was markedly elevated in PIN. In the prostate cancers, the majority of cases revealed expression of FGF6 by the prostate cancer cells themselves. In two cases, expression was present in prostatic stromal cells. Exogenous FGF6 was able to stimulate proliferation of primary prostatic epithelial and stromal cells, immortalized prostatic epithelial cells, and prostate cancer cell lines in tissue culture. FGF receptor 4, which is the most potent FGF receptor for FGF6, is expressed in the human prostate in vivo and in all of the cultured cell lines. Thus, FGF6 is increased in PIN and prostate cancer and can promote the proliferation of the transformed prostatic epithelial cells via paracrine and autocrine mechanisms.  (+info)

Prostatic Intraepithelial Neoplasia (PIN) is a term used in pathology to describe the abnormal growth of cells within the lining of the prostate gland's ducts and acini (small sacs that produce and store fluids). PIN is not considered a cancer, but it can be a precursor to prostate cancer.

There are two types of PIN: low-grade and high-grade. Low-grade PIN shows mild to moderate atypia (abnormalities in the cells), while high-grade PIN displays more significant atypia, which resembles prostate cancer. High-grade PIN is often found close to or within areas of prostate cancer, making it a potential indicator of malignancy.

However, not all cases of high-grade PIN progress to cancer, and some men with high-grade PIN may never develop prostate cancer. Nonetheless, the presence of high-grade PIN might prompt further investigation or monitoring to ensure early detection and treatment of any potential cancer development.

Prostatic neoplasms refer to abnormal growths in the prostate gland, which can be benign or malignant. The term "neoplasm" simply means new or abnormal tissue growth. When it comes to the prostate, neoplasms are often referred to as tumors.

Benign prostatic neoplasms, such as prostate adenomas, are non-cancerous overgrowths of prostate tissue. They usually grow slowly and do not spread to other parts of the body. While they can cause uncomfortable symptoms like difficulty urinating, they are generally not life-threatening.

Malignant prostatic neoplasms, on the other hand, are cancerous growths. The most common type of prostate cancer is adenocarcinoma, which arises from the glandular cells in the prostate. Prostate cancer often grows slowly and may not cause any symptoms for many years. However, some types of prostate cancer can be aggressive and spread quickly to other parts of the body, such as the bones or lymph nodes.

It's important to note that while prostate neoplasms can be concerning, early detection and treatment can significantly improve outcomes for many men. Regular check-ups with a healthcare provider are key to monitoring prostate health and catching any potential issues early on.

The prostate is a small gland that is part of the male reproductive system. Its main function is to produce a fluid that, together with sperm cells from the testicles and fluids from other glands, makes up semen. This fluid nourishes and protects the sperm, helping it to survive and facilitating its movement.

The prostate is located below the bladder and in front of the rectum. It surrounds part of the urethra, the tube that carries urine and semen out of the body. This means that prostate problems can affect urination and sexual function. The prostate gland is about the size of a walnut in adult men.

Prostate health is an important aspect of male health, particularly as men age. Common prostate issues include benign prostatic hyperplasia (BPH), which is an enlarged prostate not caused by cancer, and prostate cancer, which is one of the most common types of cancer in men. Regular check-ups with a healthcare provider can help to detect any potential problems early and improve outcomes.

Cervical intraepithelial neoplasia (CIN) is a term used to describe the abnormal growth and development of cells on the surface of the cervix. These changes are usually caused by human papillomavirus (HPV) infection, which is a common sexually transmitted infection. CIN is not cancer, but it can develop into cancer if left untreated.

The term "intraepithelial" refers to the fact that the abnormal cells are found in the epithelium, or the lining of the cervix. The term "neoplasia" means abnormal growth or development of cells. CIN is further classified into three grades based on the severity of the cell changes:

* CIN 1: Mild dysplasia (abnormal cell growth) affecting the lower third of the epithelium.
* CIN 2: Moderate dysplasia affecting the lower two-thirds of the epithelium.
* CIN 3: Severe dysplasia or carcinoma in situ, which means that the abnormal cells are found in the full thickness of the epithelium and have a high risk of progressing to invasive cancer if not treated.

It's important to note that CIN can regress on its own without treatment, especially in younger women. However, some cases may progress to invasive cervical cancer if left untreated. Regular Pap testing is recommended to detect and monitor any abnormal cell changes in the cervix. If CIN is detected, further diagnostic procedures such as a colposcopy or biopsy may be performed to determine the extent of the abnormality and guide treatment decisions.

Prostatic hyperplasia, also known as benign prostatic hyperplasia (BPH), is a noncancerous enlargement of the prostate gland. The prostate gland surrounds the urethra, the tube that carries urine and semen out of the body. When the prostate gland enlarges, it can squeeze or partially block the urethra, causing problems with urination, such as a weak stream, difficulty starting or stopping the flow, and more frequent urination, especially at night. Prostatic hyperplasia is a common condition as men age and does not necessarily lead to cancer. However, it can cause significant discomfort and decreased quality of life if left untreated. Treatment options include medications, minimally invasive procedures, and surgery.

Carcinoma in situ is a medical term used to describe the earliest stage of cancer, specifically a type of cancer that begins in the epithelial tissue, which is the tissue that lines the outer surfaces of organs and body structures. In this stage, the cancer cells are confined to the layer of cells where they first developed and have not spread beyond that layer into the surrounding tissues or organs.

Carcinoma in situ can occur in various parts of the body, including the skin, cervix, breast, lung, prostate, bladder, and other areas. It is often detected through routine screening tests, such as Pap smears for cervical cancer or mammograms for breast cancer.

While carcinoma in situ is not invasive, it can still be a serious condition because it has the potential to develop into an invasive cancer if left untreated. Treatment options for carcinoma in situ may include surgery, radiation therapy, or other forms of treatment, depending on the location and type of cancer. It is important to consult with a healthcare provider to determine the best course of action for each individual case.

Uterine cervical neoplasms, also known as cervical cancer or cervical dysplasia, refer to abnormal growths or lesions on the lining of the cervix that have the potential to become cancerous. These growths are usually caused by human papillomavirus (HPV) infection and can be detected through routine Pap smears.

Cervical neoplasms are classified into different grades based on their level of severity, ranging from mild dysplasia (CIN I) to severe dysplasia or carcinoma in situ (CIN III). In some cases, cervical neoplasms may progress to invasive cancer if left untreated.

Risk factors for developing cervical neoplasms include early sexual activity, multiple sexual partners, smoking, and a weakened immune system. Regular Pap smears and HPV testing are recommended for early detection and prevention of cervical cancer.

Adenocarcinoma is a type of cancer that arises from glandular epithelial cells. These cells line the inside of many internal organs, including the breasts, prostate, colon, and lungs. Adenocarcinomas can occur in any of these organs, as well as in other locations where glands are present.

The term "adenocarcinoma" is used to describe a cancer that has features of glandular tissue, such as mucus-secreting cells or cells that produce hormones. These cancers often form glandular structures within the tumor mass and may produce mucus or other substances.

Adenocarcinomas are typically slow-growing and tend to spread (metastasize) to other parts of the body through the lymphatic system or bloodstream. They can be treated with surgery, radiation therapy, chemotherapy, targeted therapy, or a combination of these treatments. The prognosis for adenocarcinoma depends on several factors, including the location and stage of the cancer, as well as the patient's overall health and age.

A precancerous condition, also known as a premalignant condition, is a state of abnormal cellular growth and development that has a higher-than-normal potential to progress into cancer. These conditions are characterized by the presence of certain anomalies in the cells, such as dysplasia (abnormal changes in cell shape or size), which can indicate an increased risk for malignant transformation.

It is important to note that not all precancerous conditions will eventually develop into cancer, and some may even regress on their own. However, individuals with precancerous conditions are often at a higher risk of developing cancer compared to the general population. Regular monitoring and appropriate medical interventions, if necessary, can help manage this risk and potentially prevent or detect cancer at an early stage when it is more treatable.

Examples of precancerous conditions include:

1. Dysplasia in the cervix (cervical intraepithelial neoplasia or CIN)
2. Atypical ductal hyperplasia or lobular hyperplasia in the breast
3. Actinic keratosis on the skin
4. Leukoplakia in the mouth
5. Barrett's esophagus in the digestive tract

Regular medical check-ups, screenings, and lifestyle modifications are crucial for individuals with precancerous conditions to monitor their health and reduce the risk of cancer development.

Racemases and epimerases are two types of enzymes that are involved in the modification of the stereochemistry of molecules, particularly amino acids and sugars. Here is a brief definition for each:

1. Racemases: These are enzymes that catalyze the interconversion of D- and L-stereoisomers of amino acids or other chiral compounds. They do this by promoting the conversion of one stereoisomer to its mirror image, resulting in a racemic mixture (a 1:1 mixture of two enantiomers). Racemases are important in various biological processes, such as the biosynthesis of some amino acids and the degradation of certain carbohydrates.

Example: Alanine racemase is an enzyme that catalyzes the conversion of L-alanine to D-alanine, which is essential for bacterial cell wall biosynthesis.

2. Epimerases: These are enzymes that convert one stereoisomer (epimer) of a chiral compound into another stereoisomer by changing the configuration at a single asymmetric carbon atom while keeping the rest of the molecule unchanged. Unlike racemases, epimerases do not produce racemic mixtures but rather create specific stereoisomers.

Example: Glucose-1-phosphate epimerase is an enzyme that converts glucose-1-phosphate to galactose-1-phosphate during the Leloir pathway, which is the primary metabolic route for lactose digestion in mammals.

Both racemases and epimerases play crucial roles in various biochemical processes, including the synthesis and degradation of essential molecules like amino acids and carbohydrates.

Immunohistochemistry (IHC) is a technique used in pathology and laboratory medicine to identify specific proteins or antigens in tissue sections. It combines the principles of immunology and histology to detect the presence and location of these target molecules within cells and tissues. This technique utilizes antibodies that are specific to the protein or antigen of interest, which are then tagged with a detection system such as a chromogen or fluorophore. The stained tissue sections can be examined under a microscope, allowing for the visualization and analysis of the distribution and expression patterns of the target molecule in the context of the tissue architecture. Immunohistochemistry is widely used in diagnostic pathology to help identify various diseases, including cancer, infectious diseases, and immune-mediated disorders.

A prostatectomy is a surgical procedure where all or part of the prostate gland is removed. This surgery can be performed through various approaches such as open surgery, laparoscopic surgery, or robotic-assisted surgery. The type of prostatectomy performed depends on the reason for the surgery and the patient's individual circumstances.

There are two main types of prostatectomies: radical and simple. A radical prostatectomy is a surgical procedure to remove the entire prostate gland, seminal vesicles, and surrounding lymph nodes. This type of prostatectomy is typically performed as a treatment for prostate cancer.

A simple prostatectomy, on the other hand, involves removing only the inner part of the prostate gland that is causing symptoms such as difficulty urinating or bladder obstruction. Simple prostatectomies are usually performed to alleviate benign prostatic hyperplasia (BPH), which is a non-cancerous enlargement of the prostate gland.

Regardless of the type of prostatectomy, potential risks and complications include bleeding, infection, urinary incontinence, erectile dysfunction, and changes in sexual function. It is important for patients to discuss these risks with their healthcare provider before undergoing surgery.

Papillomavirus infections are a group of diseases caused by various types of human papillomaviruses (HPVs). These viruses infect the skin and mucous membranes, and can cause benign growths such as warts or papillomas, as well as malignant growths like cervical cancer.

There are more than 100 different types of HPVs, and they can be classified into low-risk and high-risk types based on their potential to cause cancer. Low-risk HPV types, such as HPV-6 and HPV-11, commonly cause benign genital warts and respiratory papillomas. High-risk HPV types, such as HPV-16 and HPV-18, are associated with an increased risk of developing cancer, including cervical, anal, penile, vulvar, and oropharyngeal cancers.

HPV infections are typically transmitted through sexual contact, and most sexually active individuals will acquire at least one HPV infection during their lifetime. In many cases, the immune system is able to clear the virus without any symptoms or long-term consequences. However, persistent high-risk HPV infections can lead to the development of cancer over time.

Prevention measures for HPV infections include vaccination against high-risk HPV types, safe sex practices, and regular screening for cervical cancer in women. The HPV vaccine is recommended for both boys and girls aged 11-12 years old, and can also be given to older individuals up to age 45 who have not previously been vaccinated or who have not completed the full series of shots.

Vulvar neoplasms refer to abnormal growths or tumors in the vulvar region, which is the exterior female genital area including the mons pubis, labia majora, labia minora, clitoris, and the vaginal vestibule. These neoplasms can be benign (non-cancerous) or malignant (cancerous).

Benign vulvar neoplasms may include conditions such as vulvar cysts, fibromas, lipomas, or condylomas (genital warts). They are typically slow-growing and less likely to spread or invade surrounding tissues.

Malignant vulvar neoplasms, on the other hand, are cancers that can invade nearby tissues and potentially metastasize (spread) to distant parts of the body. The most common types of malignant vulvar neoplasms are squamous cell carcinoma, vulvar melanoma, and adenocarcinoma.

Early detection and treatment of vulvar neoplasms are essential for improving prognosis and reducing the risk of complications or recurrence. Regular gynecological examinations, self-examinations, and prompt attention to any unusual symptoms or changes in the vulvar area can help ensure timely diagnosis and management.

Colposcopy is a medical procedure in which a colposcope, which is a type of microscope, is used to examine the cervix, vagina, and vulva for signs of disease or abnormalities. The colposcope allows the healthcare provider to see these areas in greater detail than is possible with the naked eye. During the procedure, the provider may take a small sample of tissue (biopsy) for further examination under a microscope.

Colposcopy is often used to investigate abnormal Pap test results or to follow up on women who have been diagnosed with certain types of cervical dysplasia (abnormal cell growth). It can also be used to diagnose and monitor other conditions, such as genital warts, inflammation, or cancer.

It is important to note that colposcopy is a diagnostic procedure and not a treatment. If abnormalities are found during the exam, additional procedures may be necessary to remove or treat them.

Papillomaviridae is a family of small, non-enveloped DNA viruses that primarily infect the epithelial cells of mammals, birds, and reptiles. The name "papillomavirus" comes from the Latin word "papilla," which means nipple or small projection, reflecting the characteristic wart-like growths (papillomas) that these viruses can cause in infected host tissues.

The family Papillomaviridae includes more than 200 distinct papillomavirus types, with each type being defined by its specific DNA sequence. Human papillomaviruses (HPVs), which are the most well-studied members of this family, are associated with a range of diseases, from benign warts and lesions to malignant cancers such as cervical, anal, penile, vulvar, and oropharyngeal cancers.

Papillomaviruses have a circular, double-stranded DNA genome that is approximately 8 kbp in size. The viral genome encodes several early (E) proteins involved in viral replication and oncogenesis, as well as late (L) proteins that form the viral capsid. The life cycle of papillomaviruses is tightly linked to the differentiation program of their host epithelial cells, with productive infection occurring primarily in the differentiated layers of the epithelium.

In summary, Papillomaviridae is a family of DNA viruses that infect epithelial cells and can cause a variety of benign and malignant diseases. Human papillomaviruses are a significant public health concern due to their association with several cancer types.

Prostate-Specific Antigen (PSA) is a glycoprotein enzyme produced by the epithelial cells of the prostate gland. It is primarily involved in liquefying semen after ejaculation, allowing sperm mobility.

In clinical medicine, PSA is used as a tumor marker, mainly for monitoring the treatment and recurrence of prostate cancer. Elevated levels of PSA can indicate inflammation, infection, benign prostatic hyperplasia (BPH), or prostate cancer. However, it's important to note that an elevated PSA level does not necessarily confirm cancer; further diagnostic tests like digital rectal examination, transrectal ultrasound, and prostate biopsy are often required for definitive diagnosis.

Doctors may also use PSA isoforms or derivatives, such as free PSA, total PSA, and PSA density, to help improve the specificity of cancer detection and differentiate between malignant and benign conditions.

Neoplasm grading is a system used by pathologists to classify the degree of abnormality in cells that make up a tumor (neoplasm). It provides an assessment of how quickly the tumor is likely to grow and spread. The grade helps doctors predict the prognosis and determine the best treatment options.

Neoplasm grading typically involves evaluating certain cellular features under a microscope, such as:

1. Differentiation or degree of maturity: This refers to how closely the tumor cells resemble their normal counterparts in terms of size, shape, and organization. Well-differentiated tumors have cells that look more like normal cells and are usually slower growing. Poorly differentiated tumors have cells that appear very abnormal and tend to grow and spread more aggressively.

2. Mitotic count: This is the number of times the tumor cells divide (mitosis) within a given area. A higher mitotic count indicates a faster-growing tumor.

3. Necrosis: This refers to areas of dead tissue within the tumor. A significant amount of necrosis may suggest a more aggressive tumor.

Based on these and other factors, pathologists assign a grade to the tumor using a standardized system, such as the Bloom-Richardson or Scarff-Bloom-Richardson grading systems for breast cancer or the Fuhrman grading system for kidney cancer. The grade usually consists of a number or a range (e.g., G1, G2, G3, or G4) or a combination of grades (e.g., low grade, intermediate grade, and high grade).

In general, higher-grade tumors have a worse prognosis than lower-grade tumors because they are more likely to grow quickly, invade surrounding tissues, and metastasize (spread) to other parts of the body. However, neoplasm grading is just one aspect of cancer diagnosis and treatment planning. Other factors, such as the stage of the disease, location of the tumor, patient's overall health, and specific molecular markers, are also considered when making treatment decisions.

Prostatitis is a medical condition that refers to inflammation of the prostate gland, which can be caused by bacterial or non-bacterial factors. It can present with various symptoms such as pain in the lower abdomen, pelvis, or genital area, difficulty and/or painful urination, ejaculation pain, and flu-like symptoms. Prostatitis can be acute or chronic, and it is important to seek medical attention for proper diagnosis and treatment.

A needle biopsy is a medical procedure in which a thin, hollow needle is used to remove a small sample of tissue from a suspicious or abnormal area of the body. The tissue sample is then examined under a microscope to check for cancer cells or other abnormalities. Needle biopsies are often used to diagnose lumps or masses that can be felt through the skin, but they can also be guided by imaging techniques such as ultrasound, CT scan, or MRI to reach areas that cannot be felt. There are several types of needle biopsy procedures, including fine-needle aspiration (FNA) and core needle biopsy. FNA uses a thin needle and gentle suction to remove fluid and cells from the area, while core needle biopsy uses a larger needle to remove a small piece of tissue. The type of needle biopsy used depends on the location and size of the abnormal area, as well as the reason for the procedure.

A vaginal smear, also known as a Pap test or Pap smear, is a medical procedure in which a sample of cells is collected from the cervix (the lower part of the uterus that opens into the vagina) and examined under a microscope. The purpose of this test is to detect abnormal cells, including precancerous changes, that may indicate the presence of cervical cancer or other conditions such as infections or inflammation.

During the procedure, a speculum is inserted into the vagina to allow the healthcare provider to visualize the cervix. A spatula or brush is then used to gently scrape cells from the surface of the cervix. The sample is spread onto a microscope slide and sent to a laboratory for analysis.

Regular Pap smears are recommended for women as part of their routine healthcare, as they can help detect abnormalities at an early stage when they are more easily treated. The frequency of Pap smears may vary depending on age, medical history, and other factors. It is important to follow the recommendations of a healthcare provider regarding the timing and frequency of Pap smears.

Disease progression is the worsening or advancement of a medical condition over time. It refers to the natural course of a disease, including its development, the severity of symptoms and complications, and the impact on the patient's overall health and quality of life. Understanding disease progression is important for developing appropriate treatment plans, monitoring response to therapy, and predicting outcomes.

The rate of disease progression can vary widely depending on the type of medical condition, individual patient factors, and the effectiveness of treatment. Some diseases may progress rapidly over a short period of time, while others may progress more slowly over many years. In some cases, disease progression may be slowed or even halted with appropriate medical interventions, while in other cases, the progression may be inevitable and irreversible.

In clinical practice, healthcare providers closely monitor disease progression through regular assessments, imaging studies, and laboratory tests. This information is used to guide treatment decisions and adjust care plans as needed to optimize patient outcomes and improve quality of life.

Transgenic mice are genetically modified rodents that have incorporated foreign DNA (exogenous DNA) into their own genome. This is typically done through the use of recombinant DNA technology, where a specific gene or genetic sequence of interest is isolated and then introduced into the mouse embryo. The resulting transgenic mice can then express the protein encoded by the foreign gene, allowing researchers to study its function in a living organism.

The process of creating transgenic mice usually involves microinjecting the exogenous DNA into the pronucleus of a fertilized egg, which is then implanted into a surrogate mother. The offspring that result from this procedure are screened for the presence of the foreign DNA, and those that carry the desired genetic modification are used to establish a transgenic mouse line.

Transgenic mice have been widely used in biomedical research to model human diseases, study gene function, and test new therapies. They provide a valuable tool for understanding complex biological processes and developing new treatments for a variety of medical conditions.

PTEN phosphohydrolase, also known as PTEN protein or phosphatase and tensin homolog deleted on chromosome ten, is a tumor suppressor protein that plays a crucial role in regulating cell growth and division. It works by dephosphorylating (removing a phosphate group from) the lipid second messenger PIP3, which is involved in signaling pathways that promote cell proliferation and survival. By negatively regulating these pathways, PTEN helps to prevent uncontrolled cell growth and tumor formation. Mutations in the PTEN gene can lead to a variety of cancer types, including breast, prostate, and endometrial cancer.

The cervix uteri, often simply referred to as the cervix, is the lower part of the uterus (womb) that connects to the vagina. It has an opening called the external os through which menstrual blood exits the uterus and sperm enters during sexual intercourse. During childbirth, the cervix dilates or opens to allow for the passage of the baby through the birth canal.

A biopsy is a medical procedure in which a small sample of tissue is taken from the body to be examined under a microscope for the presence of disease. This can help doctors diagnose and monitor various medical conditions, such as cancer, infections, or autoimmune disorders. The type of biopsy performed will depend on the location and nature of the suspected condition. Some common types of biopsies include:

1. Incisional biopsy: In this procedure, a surgeon removes a piece of tissue from an abnormal area using a scalpel or other surgical instrument. This type of biopsy is often used when the lesion is too large to be removed entirely during the initial biopsy.

2. Excisional biopsy: An excisional biopsy involves removing the entire abnormal area, along with a margin of healthy tissue surrounding it. This technique is typically employed for smaller lesions or when cancer is suspected.

3. Needle biopsy: A needle biopsy uses a thin, hollow needle to extract cells or fluid from the body. There are two main types of needle biopsies: fine-needle aspiration (FNA) and core needle biopsy. FNA extracts loose cells, while a core needle biopsy removes a small piece of tissue.

4. Punch biopsy: In a punch biopsy, a round, sharp tool is used to remove a small cylindrical sample of skin tissue. This type of biopsy is often used for evaluating rashes or other skin abnormalities.

5. Shave biopsy: During a shave biopsy, a thin slice of tissue is removed from the surface of the skin using a sharp razor-like instrument. This technique is typically used for superficial lesions or growths on the skin.

After the biopsy sample has been collected, it is sent to a laboratory where a pathologist will examine the tissue under a microscope and provide a diagnosis based on their findings. The results of the biopsy can help guide further treatment decisions and determine the best course of action for managing the patient's condition.

Prostatic diseases refer to a range of medical conditions that affect the prostate gland, a small gland that is part of the male reproductive system. The prostate is located below the bladder and surrounds the urethra, the tube that carries urine and semen out of the body. Some common prostatic diseases include:

1. Benign Prostatic Hyperplasia (BPH): This is a non-cancerous enlargement of the prostate gland that can cause difficulties with urination, such as a weak stream, frequent urination, and a feeling of incomplete bladder emptying.
2. Prostatitis: This is an inflammation or infection of the prostate gland that can cause pain, fever, difficulty urinating, and sexual dysfunction.
3. Prostate Cancer: This is a malignant tumor that develops in the prostate gland and can spread to other parts of the body. It is one of the most common types of cancer in men and can often be treated successfully if detected early.
4. Acute Bacterial Prostatitis: This is a sudden and severe infection of the prostate gland that can cause fever, chills, pain in the lower back and genital area, and difficulty urinating.
5. Chronic Bacterial Prostatitis: This is a recurring or persistent bacterial infection of the prostate gland that can cause symptoms similar to chronic pelvic pain syndrome.
6. Chronic Pelvic Pain Syndrome (CPPS): Also known as chronic nonbacterial prostatitis, this condition is characterized by ongoing pain in the pelvic area, often accompanied by urinary and sexual dysfunction. The exact cause of CPPS is not well understood, but it is thought to be related to inflammation or nerve damage in the prostate gland.

Vaginal neoplasms refer to abnormal growths or tumors in the vagina. These growths can be benign (non-cancerous) or malignant (cancerous). The two main types of vaginal neoplasms are:

1. Vaginal intraepithelial neoplasia (VAIN): This is a condition where the cells on the inner lining of the vagina become abnormal but have not invaded deeper tissues. VAIN can be low-grade or high-grade, depending on the severity of the cell changes.
2. Vaginal cancer: This is a malignant tumor that arises from the cells in the vagina. The two main types of vaginal cancer are squamous cell carcinoma and adenocarcinoma. Squamous cell carcinoma is the most common type, accounting for about 85% of all cases.

Risk factors for vaginal neoplasms include human papillomavirus (HPV) infection, smoking, older age, history of cervical cancer or precancerous changes, and exposure to diethylstilbestrol (DES) in utero. Treatment options depend on the type, stage, and location of the neoplasm but may include surgery, radiation therapy, chemotherapy, or a combination of these approaches.

Tumor markers are substances that can be found in the body and their presence can indicate the presence of certain types of cancer or other conditions. Biological tumor markers refer to those substances that are produced by cancer cells or by other cells in response to cancer or certain benign (non-cancerous) conditions. These markers can be found in various bodily fluids such as blood, urine, or tissue samples.

Examples of biological tumor markers include:

1. Proteins: Some tumor markers are proteins that are produced by cancer cells or by other cells in response to the presence of cancer. For example, prostate-specific antigen (PSA) is a protein produced by normal prostate cells and in higher amounts by prostate cancer cells.
2. Genetic material: Tumor markers can also include genetic material such as DNA, RNA, or microRNA that are shed by cancer cells into bodily fluids. For example, circulating tumor DNA (ctDNA) is genetic material from cancer cells that can be found in the bloodstream.
3. Metabolites: Tumor markers can also include metabolic products produced by cancer cells or by other cells in response to cancer. For example, lactate dehydrogenase (LDH) is an enzyme that is released into the bloodstream when cancer cells break down glucose for energy.

It's important to note that tumor markers are not specific to cancer and can be elevated in non-cancerous conditions as well. Therefore, they should not be used alone to diagnose cancer but rather as a tool in conjunction with other diagnostic tests and clinical evaluations.

Glutathione S-transferase Pi (GSTP1) is a member of the glutathione S-transferase (GST) family, which are enzymes involved in the detoxification of xenobiotics and endogenous compounds. GSTs catalyze the conjugation of reduced glutathione to these electrophilic compounds, facilitating their excretion from the body.

GSTP1 is primarily found in the cytosol of cells and has a high affinity for a variety of substrates, including polycyclic aromatic hydrocarbons, heterocyclic amines, and certain chemotherapeutic drugs. It plays an essential role in protecting cells against oxidative stress and chemical-induced damage.

Polymorphisms in the GSTP1 gene have been associated with altered enzyme activity and susceptibility to various diseases, including cancer, neurological disorders, and respiratory diseases. The most common polymorphism in GSTP1 is a single nucleotide substitution (Ile105Val), which has been shown to reduce the enzyme's catalytic activity and increase the risk of developing certain types of cancer.

A tumor virus infection is a condition in which a person's cells become cancerous or transformed due to the integration and disruption of normal cellular functions by a viral pathogen. These viruses are also known as oncoviruses, and they can cause tumors or cancer by altering the host cell's genetic material, promoting uncontrolled cell growth and division, evading immune surveillance, and inhibiting apoptosis (programmed cell death).

Examples of tumor viruses include:

1. DNA tumor viruses: These are double-stranded DNA viruses that can cause cancer in humans. Examples include human papillomavirus (HPV), hepatitis B virus (HBV), and Merkel cell polyomavirus (MCV).
2. RNA tumor viruses: Also known as retroviruses, these single-stranded RNA viruses can cause cancer in humans. Examples include human T-cell leukemia virus type 1 (HTLV-1) and human immunodeficiency virus (HIV).

Tumor virus infections are responsible for approximately 15-20% of all cancer cases worldwide, making them a significant public health concern. Prevention strategies, such as vaccination against HPV and HBV, have been shown to reduce the incidence of associated cancers.

Uterine cervical dysplasia is a condition characterized by abnormal cell growth on the lining of the cervix, which is the lower part of the uterus that connects to the vagina. It is also known as cervical intraepithelial neoplasia (CIN).

Cervical dysplasia can be caused by certain strains of human papillomavirus (HPV), a common sexually transmitted infection. The abnormal cells may develop into cancerous cells over time, although not all cases of cervical dysplasia will progress to cancer.

Cervical dysplasia is typically detected through a Pap test or HPV test, which are screening tests used to detect precancerous changes in the cervix. Depending on the severity and extent of the abnormal cells, treatment options may include close monitoring, surgical removal of the affected tissue, or more extensive surgery.

It is important for women to receive regular Pap tests and HPV tests as recommended by their healthcare provider to detect and treat cervical dysplasia early, before it has a chance to progress to cancer.

Anus neoplasms refer to abnormal growths or tumors in the anus, which is the opening at the end of the digestive tract where solid waste leaves the body. These growths can be benign (non-cancerous) or malignant (cancerous). Common types of anus neoplasms include squamous cell carcinoma, adenocarcinoma, and melanoma.

Squamous cell carcinoma is the most common type of anus cancer, accounting for about 80% of all cases. It begins in the squamous cells that line the anal canal and can spread to other parts of the body if left untreated.

Adenocarcinoma is a less common type of anus cancer that arises from glandular cells in the anus. This type of cancer is often associated with long-standing inflammatory conditions, such as anal fistulas or ulcerative colitis.

Melanoma is a rare form of skin cancer that can also occur in the anus. It develops from pigment-producing cells called melanocytes and tends to be aggressive with a high risk of spreading to other parts of the body.

Other less common types of anus neoplasms include basal cell carcinoma, sarcoma, and lymphoma. Treatment options for anus neoplasms depend on the type, stage, and location of the tumor, as well as the patient's overall health.

Neoplastic gene expression regulation refers to the processes that control the production of proteins and other molecules from genes in neoplastic cells, or cells that are part of a tumor or cancer. In a normal cell, gene expression is tightly regulated to ensure that the right genes are turned on or off at the right time. However, in cancer cells, this regulation can be disrupted, leading to the overexpression or underexpression of certain genes.

Neoplastic gene expression regulation can be affected by a variety of factors, including genetic mutations, epigenetic changes, and signals from the tumor microenvironment. These changes can lead to the activation of oncogenes (genes that promote cancer growth and development) or the inactivation of tumor suppressor genes (genes that prevent cancer).

Understanding neoplastic gene expression regulation is important for developing new therapies for cancer, as targeting specific genes or pathways involved in this process can help to inhibit cancer growth and progression.

Electrosurgery is a surgical procedure that uses high-frequency electrical currents to cut, coagulate, or fulgurate tissue. It is often used in surgical procedures as an alternative to traditional scalpels and electrocautery. The electrical currents are delivered through a specialized instrument called an electrosurgical unit (ESU) that can be set to produce different forms of energy, including cutting, coagulation, or blended currents.

During the procedure, the ESU is used to apply electrical energy to the target tissue, which responds by heating up and vaporizing, allowing for precise cuts to be made. The heat generated during the procedure also helps to seal off blood vessels and nerve endings, reducing bleeding and minimizing post-operative pain.

Electrosurgery is commonly used in a variety of surgical procedures, including dermatology, gynecology, urology, orthopedics, and general surgery. It offers several advantages over traditional surgical techniques, such as reduced blood loss, shorter operating times, and faster recovery times for patients. However, it also requires specialized training and equipment to ensure safe and effective use.

Androgen receptors (ARs) are a type of nuclear receptor protein that are expressed in various tissues throughout the body. They play a critical role in the development and maintenance of male sexual characteristics and reproductive function. ARs are activated by binding to androgens, which are steroid hormones such as testosterone and dihydrotestosterone (DHT). Once activated, ARs function as transcription factors that regulate gene expression, ultimately leading to various cellular responses.

In the context of medical definitions, androgen receptors can be defined as follows:

Androgen receptors are a type of nuclear receptor protein that bind to androgens, such as testosterone and dihydrotestosterone, and mediate their effects on gene expression in various tissues. They play critical roles in the development and maintenance of male sexual characteristics and reproductive function, and are involved in the pathogenesis of several medical conditions, including prostate cancer, benign prostatic hyperplasia, and androgen deficiency syndromes.

Immunoenzyme techniques are a group of laboratory methods used in immunology and clinical chemistry that combine the specificity of antibody-antigen reactions with the sensitivity and amplification capabilities of enzyme reactions. These techniques are primarily used for the detection, quantitation, or identification of various analytes (such as proteins, hormones, drugs, viruses, or bacteria) in biological samples.

In immunoenzyme techniques, an enzyme is linked to an antibody or antigen, creating a conjugate. This conjugate then interacts with the target analyte in the sample, forming an immune complex. The presence and amount of this immune complex can be visualized or measured by detecting the enzymatic activity associated with it.

There are several types of immunoenzyme techniques, including:

1. Enzyme-linked Immunosorbent Assay (ELISA): A widely used method for detecting and quantifying various analytes in a sample. In ELISA, an enzyme is attached to either the capture antibody or the detection antibody. After the immune complex formation, a substrate is added that reacts with the enzyme, producing a colored product that can be measured spectrophotometrically.
2. Immunoblotting (Western blot): A method used for detecting specific proteins in a complex mixture, such as a protein extract from cells or tissues. In this technique, proteins are separated by gel electrophoresis and transferred to a membrane, where they are probed with an enzyme-conjugated antibody directed against the target protein.
3. Immunohistochemistry (IHC): A method used for detecting specific antigens in tissue sections or cells. In IHC, an enzyme-conjugated primary or secondary antibody is applied to the sample, and the presence of the antigen is visualized using a chromogenic substrate that produces a colored product at the site of the antigen-antibody interaction.
4. Immunofluorescence (IF): A method used for detecting specific antigens in cells or tissues by employing fluorophore-conjugated antibodies. The presence of the antigen is visualized using a fluorescence microscope.
5. Enzyme-linked immunosorbent assay (ELISA): A method used for detecting and quantifying specific antigens or antibodies in liquid samples, such as serum or culture supernatants. In ELISA, an enzyme-conjugated detection antibody is added after the immune complex formation, and a substrate is added that reacts with the enzyme to produce a colored product that can be measured spectrophotometrically.

These techniques are widely used in research and diagnostic laboratories for various applications, including protein characterization, disease diagnosis, and monitoring treatment responses.

Epithelium is the tissue that covers the outer surface of the body, lines the internal cavities and organs, and forms various glands. It is composed of one or more layers of tightly packed cells that have a uniform shape and size, and rest on a basement membrane. Epithelial tissues are avascular, meaning they do not contain blood vessels, and are supplied with nutrients by diffusion from the underlying connective tissue.

Epithelial cells perform a variety of functions, including protection, secretion, absorption, excretion, and sensation. They can be classified based on their shape and the number of cell layers they contain. The main types of epithelium are:

1. Squamous epithelium: composed of flat, scalelike cells that fit together like tiles on a roof. It forms the lining of blood vessels, air sacs in the lungs, and the outermost layer of the skin.
2. Cuboidal epithelium: composed of cube-shaped cells with equal height and width. It is found in glands, tubules, and ducts.
3. Columnar epithelium: composed of tall, rectangular cells that are taller than they are wide. It lines the respiratory, digestive, and reproductive tracts.
4. Pseudostratified epithelium: appears stratified or layered but is actually made up of a single layer of cells that vary in height. The nuclei of these cells appear at different levels, giving the tissue a stratified appearance. It lines the respiratory and reproductive tracts.
5. Transitional epithelium: composed of several layers of cells that can stretch and change shape to accommodate changes in volume. It is found in the urinary bladder and ureters.

Epithelial tissue provides a barrier between the internal and external environments, protecting the body from physical, chemical, and biological damage. It also plays a crucial role in maintaining homeostasis by regulating the exchange of substances between the body and its environment.

Neoplasm invasiveness is a term used in pathology and oncology to describe the aggressive behavior of cancer cells as they invade surrounding tissues and organs. This process involves the loss of cell-to-cell adhesion, increased motility and migration, and the ability of cancer cells to degrade the extracellular matrix (ECM) through the production of enzymes such as matrix metalloproteinases (MMPs).

Invasive neoplasms are cancers that have spread beyond the original site where they first developed and have infiltrated adjacent tissues or structures. This is in contrast to non-invasive or in situ neoplasms, which are confined to the epithelial layer where they originated and have not yet invaded the underlying basement membrane.

The invasiveness of a neoplasm is an important prognostic factor in cancer diagnosis and treatment, as it can indicate the likelihood of metastasis and the potential effectiveness of various therapies. In general, more invasive cancers are associated with worse outcomes and require more aggressive treatment approaches.

Epithelial cells are types of cells that cover the outer surfaces of the body, line the inner surfaces of organs and glands, and form the lining of blood vessels and body cavities. They provide a protective barrier against the external environment, regulate the movement of materials between the internal and external environments, and are involved in the sense of touch, temperature, and pain. Epithelial cells can be squamous (flat and thin), cuboidal (square-shaped and of equal height), or columnar (tall and narrow) in shape and are classified based on their location and function.

Atrophy is a medical term that refers to the decrease in size and wasting of an organ or tissue due to the disappearance of cells, shrinkage of cells, or decreased number of cells. This process can be caused by various factors such as disuse, aging, degeneration, injury, or disease.

For example, if a muscle is immobilized for an extended period, it may undergo atrophy due to lack of use. Similarly, certain medical conditions like diabetes, cancer, and heart failure can lead to the wasting away of various tissues and organs in the body.

Atrophy can also occur as a result of natural aging processes, leading to decreased muscle mass and strength in older adults. In general, atrophy is characterized by a decrease in the volume or weight of an organ or tissue, which can have significant impacts on its function and overall health.

The Papanicolaou (Pap) test, also known as the Pap smear, is a screening procedure for detecting precancerous and cancerous cells in the cervix. It involves collecting cells from the cervix and examining them under a microscope to look for any abnormalities. The test is typically recommended for women aged 21-65 as part of routine pelvic exams, with the frequency depending on age and risk factors.

The Pap test was developed by Georgios Papanikolaou in the early 20th century and has since become a widely used and important tool in preventing cervical cancer. The test is usually performed in a healthcare provider's office and takes only a few minutes to complete. It is a relatively simple, safe, and painless procedure that can help detect cervical abnormalities at an early stage, when they are most treatable.

Tissue Microarray (TMA) analysis is a surgical pathology technique that allows for the simultaneous analysis of multiple tissue samples (known as "cores") from different patients or even different regions of the same tumor, on a single microscope slide. This technique involves the extraction of small cylindrical samples of tissue, which are then arrayed in a grid-like pattern on a recipient paraffin block. Once the TMA is created, sections can be cut and stained with various histochemical or immunohistochemical stains to evaluate the expression of specific proteins or other molecules of interest.

Tissue Array Analysis has become an important tool in biomedical research, enabling high-throughput analysis of tissue samples for molecular markers, gene expression patterns, and other features that can help inform clinical decision making, drug development, and our understanding of disease processes. It's widely used in cancer research to study the heterogeneity of tumors, identify new therapeutic targets, and evaluate patient prognosis.

Neoplastic cell transformation is a process in which a normal cell undergoes genetic alterations that cause it to become cancerous or malignant. This process involves changes in the cell's DNA that result in uncontrolled cell growth and division, loss of contact inhibition, and the ability to invade surrounding tissues and metastasize (spread) to other parts of the body.

Neoplastic transformation can occur as a result of various factors, including genetic mutations, exposure to carcinogens, viral infections, chronic inflammation, and aging. These changes can lead to the activation of oncogenes or the inactivation of tumor suppressor genes, which regulate cell growth and division.

The transformation of normal cells into cancerous cells is a complex and multi-step process that involves multiple genetic and epigenetic alterations. It is characterized by several hallmarks, including sustained proliferative signaling, evasion of growth suppressors, resistance to cell death, enabling replicative immortality, induction of angiogenesis, activation of invasion and metastasis, reprogramming of energy metabolism, and evading immune destruction.

Neoplastic cell transformation is a fundamental concept in cancer biology and is critical for understanding the molecular mechanisms underlying cancer development and progression. It also has important implications for cancer diagnosis, prognosis, and treatment, as identifying the specific genetic alterations that underlie neoplastic transformation can help guide targeted therapies and personalized medicine approaches.

Human papillomavirus 16 (HPV16) is a specific type of human papillomavirus (HPV). HPV is a DNA virus that infects the skin and mucous membranes, and there are over 200 types of HPV. Some types of HPV can cause warts, while others are associated with an increased risk of certain cancers.

HPV16 is one of the high-risk types of HPV and is strongly associated with several types of cancer, including cervical, anal, penile, vulvar, and oropharyngeal (throat) cancers. HPV16 is responsible for about 50% of all cervical cancers and is the most common high-risk type of HPV found in these cancers.

HPV16 is typically transmitted through sexual contact, and most people who are sexually active will acquire at least one type of HPV at some point in their lives. While HPV infections are often harmless and clear up on their own without causing any symptoms or health problems, high-risk types like HPV16 can lead to cancer if left untreated.

Fortunately, there are vaccines available that protect against HPV16 and other high-risk types of HPV. These vaccines have been shown to be highly effective in preventing HPV-related cancers and precancerous lesions. The Centers for Disease Control and Prevention (CDC) recommends routine HPV vaccination for both boys and girls starting at age 11 or 12, although the vaccine can be given as early as age 9. Catch-up vaccinations are also recommended for older individuals who have not yet been vaccinated.

Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.

The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.

Examples of animal disease models include:

1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.

Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.

Conization is a surgical procedure that involves the removal of a cone-shaped piece of tissue from the cervix. It is typically performed to diagnose or treat abnormal or precancerous cells in the cervix, and is also known as a cone biopsy or a cervical conization.

The procedure is usually done under general anesthesia, and involves using a surgical instrument such as a scalpel or a laser to remove a cone-shaped piece of tissue from the cervix. The tissue is then sent to a laboratory for examination under a microscope to determine whether there are any abnormal or precancerous cells present.

Conization may be recommended in cases where Pap tests or other screening methods have detected abnormal cells in the cervix, or if there are suspicious-looking areas that cannot be fully evaluated with a colposcopy (a procedure that uses a special magnifying device to examine the cervix). It may also be used as a treatment for certain types of cervical dysplasia (abnormal cell growth) or early-stage cervical cancer.

It's important to note that conization is a surgical procedure and, like any surgery, carries some risks such as bleeding, infection, and damage to surrounding tissues. However, these complications are generally rare and can be effectively managed with appropriate medical care.

Keratins are a type of fibrous structural proteins that constitute the main component of the integumentary system, which includes the hair, nails, and skin of vertebrates. They are also found in other tissues such as horns, hooves, feathers, and reptilian scales. Keratins are insoluble proteins that provide strength, rigidity, and protection to these structures.

Keratins are classified into two types: soft keratins (Type I) and hard keratins (Type II). Soft keratins are found in the skin and simple epithelial tissues, while hard keratins are present in structures like hair, nails, horns, and hooves.

Keratin proteins have a complex structure consisting of several domains, including an alpha-helical domain, beta-pleated sheet domain, and a non-repetitive domain. These domains provide keratin with its unique properties, such as resistance to heat, chemicals, and mechanical stress.

In summary, keratins are fibrous structural proteins that play a crucial role in providing strength, rigidity, and protection to various tissues in the body.

In situ hybridization (ISH) is a molecular biology technique used to detect and localize specific nucleic acid sequences, such as DNA or RNA, within cells or tissues. This technique involves the use of a labeled probe that is complementary to the target nucleic acid sequence. The probe can be labeled with various types of markers, including radioisotopes, fluorescent dyes, or enzymes.

During the ISH procedure, the labeled probe is hybridized to the target nucleic acid sequence in situ, meaning that the hybridization occurs within the intact cells or tissues. After washing away unbound probe, the location of the labeled probe can be visualized using various methods depending on the type of label used.

In situ hybridization has a wide range of applications in both research and diagnostic settings, including the detection of gene expression patterns, identification of viral infections, and diagnosis of genetic disorders.

Human papillomavirus 18 (HPV-18) is a specific type of human papillomavirus (HPV), which is a group of more than 200 related viruses. HPV is named for the warts (papillomas) some types can cause.

HPV-18 is one of the high-risk types of HPV that are linked to several types of cancer, including cervical, anal, vaginal, vulvar, and oropharyngeal (throat) cancers. HPV-18 along with HPV-16 are responsible for about 70% of all cervical cancers.

HPV is passed from one person to another during skin-to-skin contact, usually during sexual activity. Most sexually active people will have an HPV infection at some point in their lives, but most will never know it because the virus often causes no symptoms and goes away on its own. However, when HPV doesn't go away, it can cause serious health problems, including cancer.

There are vaccines available to protect against HPV-18 and other high-risk types of HPV. The Centers for Disease Control and Prevention (CDC) recommends that all boys and girls get the HPV vaccine at age 11 or 12, but it can be given as early as age 9 and until age 26 for those who have not yet received it. The vaccine is most effective when given before becoming sexually active.

Neoplasm staging is a systematic process used in medicine to describe the extent of spread of a cancer, including the size and location of the original (primary) tumor and whether it has metastasized (spread) to other parts of the body. The most widely accepted system for this purpose is the TNM classification system developed by the American Joint Committee on Cancer (AJCC) and the Union for International Cancer Control (UICC).

In this system, T stands for tumor, and it describes the size and extent of the primary tumor. N stands for nodes, and it indicates whether the cancer has spread to nearby lymph nodes. M stands for metastasis, and it shows whether the cancer has spread to distant parts of the body.

Each letter is followed by a number that provides more details about the extent of the disease. For example, a T1N0M0 cancer means that the primary tumor is small and has not spread to nearby lymph nodes or distant sites. The higher the numbers, the more advanced the cancer.

Staging helps doctors determine the most appropriate treatment for each patient and estimate the patient's prognosis. It is an essential tool for communication among members of the healthcare team and for comparing outcomes of treatments in clinical trials.

Alphapapillomavirus is a genus of Papillomaviridae, a family of small, non-enveloped DNA viruses that infect the skin and mucous membranes of humans and other animals. Members of this genus are known to cause various types of benign and malignant tumors in humans, including skin warts, genital warts, and cancers of the cervix, anus, penis, vulva, and oropharynx.

The Alphapapillomavirus genus is further divided into several species, each containing multiple types or strains of the virus. Some of the most well-known and studied types of Alphapapillomavirus include:

* Human papillomavirus (HPV) type 16 and 18, which are associated with a high risk of cervical cancer and other anogenital cancers
* HPV type 6 and 11, which are commonly found in genital warts and recurrent respiratory papillomatosis
* HPV types 31, 33, 45, 52, and 58, which are also associated with an increased risk of cervical cancer and other malignancies.

Preventive measures such as vaccination against high-risk HPV types have been shown to significantly reduce the incidence of cervical cancer and other HPV-related diseases. Regular screening for cervical cancer and other precancerous lesions is also an important part of prevention and early detection.

Carcinoma is a type of cancer that develops from epithelial cells, which are the cells that line the inner and outer surfaces of the body. These cells cover organs, glands, and other structures within the body. Carcinomas can occur in various parts of the body, including the skin, lungs, breasts, prostate, colon, and pancreas. They are often characterized by the uncontrolled growth and division of abnormal cells that can invade surrounding tissues and spread to other parts of the body through a process called metastasis. Carcinomas can be further classified based on their appearance under a microscope, such as adenocarcinoma, squamous cell carcinoma, and basal cell carcinoma.

A transgene is a segment of DNA that has been artificially transferred from one organism to another, typically between different species, to introduce a new trait or characteristic. The term "transgene" specifically refers to the genetic material that has been transferred and has become integrated into the host organism's genome. This technology is often used in genetic engineering and biomedical research, including the development of genetically modified organisms (GMOs) for agricultural purposes or the creation of animal models for studying human diseases.

Transgenes can be created using various techniques, such as molecular cloning, where a desired gene is isolated, manipulated, and then inserted into a vector (a small DNA molecule, such as a plasmid) that can efficiently enter the host organism's cells. Once inside the cell, the transgene can integrate into the host genome, allowing for the expression of the new trait in the resulting transgenic organism.

It is important to note that while transgenes can provide valuable insights and benefits in research and agriculture, their use and release into the environment are subjects of ongoing debate due to concerns about potential ecological impacts and human health risks.

A neoplasm is a tumor or growth that is formed by an abnormal and excessive proliferation of cells, which can be benign or malignant. Neoplasm proteins are therefore any proteins that are expressed or produced in these neoplastic cells. These proteins can play various roles in the development, progression, and maintenance of neoplasms.

Some neoplasm proteins may contribute to the uncontrolled cell growth and division seen in cancer, such as oncogenic proteins that promote cell cycle progression or inhibit apoptosis (programmed cell death). Others may help the neoplastic cells evade the immune system, allowing them to proliferate undetected. Still others may be involved in angiogenesis, the formation of new blood vessels that supply the tumor with nutrients and oxygen.

Neoplasm proteins can also serve as biomarkers for cancer diagnosis, prognosis, or treatment response. For example, the presence or level of certain neoplasm proteins in biological samples such as blood or tissue may indicate the presence of a specific type of cancer, help predict the likelihood of cancer recurrence, or suggest whether a particular therapy will be effective.

Overall, understanding the roles and behaviors of neoplasm proteins can provide valuable insights into the biology of cancer and inform the development of new diagnostic and therapeutic strategies.

Viral DNA refers to the genetic material present in viruses that consist of DNA as their core component. Deoxyribonucleic acid (DNA) is one of the two types of nucleic acids that are responsible for storing and transmitting genetic information in living organisms. Viruses are infectious agents much smaller than bacteria that can only replicate inside the cells of other organisms, called hosts.

Viral DNA can be double-stranded (dsDNA) or single-stranded (ssDNA), depending on the type of virus. Double-stranded DNA viruses have a genome made up of two complementary strands of DNA, while single-stranded DNA viruses contain only one strand of DNA.

Examples of dsDNA viruses include Adenoviruses, Herpesviruses, and Poxviruses, while ssDNA viruses include Parvoviruses and Circoviruses. Viral DNA plays a crucial role in the replication cycle of the virus, encoding for various proteins necessary for its multiplication and survival within the host cell.

Pancreatic ductal carcinoma (PDC) is a specific type of cancer that forms in the ducts that carry digestive enzymes out of the pancreas. It's the most common form of exocrine pancreatic cancer, making up about 90% of all cases.

The symptoms of PDC are often vague and can include abdominal pain, jaundice (yellowing of the skin and eyes), unexplained weight loss, and changes in bowel movements. These symptoms can be similar to those caused by other less serious conditions, which can make diagnosis difficult.

Pancreatic ductal carcinoma is often aggressive and difficult to treat. The prognosis for PDC is generally poor, with a five-year survival rate of only about 9%. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these approaches. However, because PDC is often not detected until it has advanced, treatment is frequently focused on palliative care to relieve symptoms and improve quality of life.

Squamous cell neoplasms are abnormal growths or tumors that originate from squamous cells, which are flat, scale-like cells that make up the outer layer of the skin and the lining of mucous membranes. These neoplasms can be benign (noncancerous) or malignant (cancerous). When malignant, they are called squamous cell carcinomas.

Squamous cell carcinomas often develop in areas exposed to excessive sunlight or ultraviolet radiation, such as the skin, lips, and mouth. They can also occur in other areas of the body, including the cervix, anus, and lungs. Risk factors for developing squamous cell carcinoma include fair skin, a history of sunburns, exposure to certain chemicals or radiation, and a weakened immune system.

Symptoms of squamous cell carcinomas may include rough or scaly patches on the skin, a sore that doesn't heal, a wart-like growth, or a raised bump with a central depression. Treatment for squamous cell carcinomas typically involves surgical removal of the tumor, along with radiation therapy or chemotherapy in some cases. Early detection and treatment can help prevent the spread of the cancer to other parts of the body.

'Condylomata Acuminata' is the medical term for genital warts, which are growths or bumps that appear on the genital area. They are caused by certain types of the human papillomavirus (HPV). Genital warts can vary in appearance, and they may be small, flat, and difficult to see or large, cauliflower-like, and easily visible.

The warts can appear on the vulva, vagina, cervix, rectum, anus, penis, or scrotum. They are usually painless but can cause discomfort during sexual intercourse. In some cases, genital warts can lead to serious health problems, such as cervical cancer in women.

It is important to note that not all people with HPV will develop genital warts, and many people with HPV are asymptomatic and unaware they have the virus. The Centers for Disease Control and Prevention (CDC) recommends routine HPV vaccination for both boys and girls aged 11-12 years to prevent HPV infection and related diseases, including genital warts.

Cell proliferation is the process by which cells increase in number, typically through the process of cell division. In the context of biology and medicine, it refers to the reproduction of cells that makes up living tissue, allowing growth, maintenance, and repair. It involves several stages including the transition from a phase of quiescence (G0 phase) to an active phase (G1 phase), DNA replication in the S phase, and mitosis or M phase, where the cell divides into two daughter cells.

Abnormal or uncontrolled cell proliferation is a characteristic feature of many diseases, including cancer, where deregulated cell cycle control leads to excessive and unregulated growth of cells, forming tumors that can invade surrounding tissues and metastasize to distant sites in the body.

A cell line that is derived from tumor cells and has been adapted to grow in culture. These cell lines are often used in research to study the characteristics of cancer cells, including their growth patterns, genetic changes, and responses to various treatments. They can be established from many different types of tumors, such as carcinomas, sarcomas, and leukemias. Once established, these cell lines can be grown and maintained indefinitely in the laboratory, allowing researchers to conduct experiments and studies that would not be feasible using primary tumor cells. It is important to note that tumor cell lines may not always accurately represent the behavior of the original tumor, as they can undergo genetic changes during their time in culture.

Glutathione transferases (GSTs) are a group of enzymes involved in the detoxification of xenobiotics and endogenous compounds. They facilitate the conjugation of these compounds with glutathione, a tripeptide consisting of cysteine, glutamic acid, and glycine, which results in more water-soluble products that can be easily excreted from the body.

GSTs play a crucial role in protecting cells against oxidative stress and chemical injury by neutralizing reactive electrophilic species and peroxides. They are found in various tissues, including the liver, kidneys, lungs, and intestines, and are classified into several families based on their structure and function.

Abnormalities in GST activity have been associated with increased susceptibility to certain diseases, such as cancer, neurological disorders, and respiratory diseases. Therefore, GSTs have become a subject of interest in toxicology, pharmacology, and clinical research.

Tumor suppressor proteins are a type of regulatory protein that helps control the cell cycle and prevent cells from dividing and growing in an uncontrolled manner. They work to inhibit tumor growth by preventing the formation of tumors or slowing down their progression. These proteins can repair damaged DNA, regulate gene expression, and initiate programmed cell death (apoptosis) if the damage is too severe for repair.

Mutations in tumor suppressor genes, which provide the code for these proteins, can lead to a decrease or loss of function in the resulting protein. This can result in uncontrolled cell growth and division, leading to the formation of tumors and cancer. Examples of tumor suppressor proteins include p53, Rb (retinoblastoma), and BRCA1/2.

Squamous cell carcinoma is a type of skin cancer that begins in the squamous cells, which are flat, thin cells that form the outer layer of the skin (epidermis). It commonly occurs on sun-exposed areas such as the face, ears, lips, and backs of the hands. Squamous cell carcinoma can also develop in other areas of the body including the mouth, lungs, and cervix.

This type of cancer usually develops slowly and may appear as a rough or scaly patch of skin, a red, firm nodule, or a sore or ulcer that doesn't heal. While squamous cell carcinoma is not as aggressive as some other types of cancer, it can metastasize (spread) to other parts of the body if left untreated, making early detection and treatment important.

Risk factors for developing squamous cell carcinoma include prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds, fair skin, a history of sunburns, a weakened immune system, and older age. Prevention measures include protecting your skin from the sun by wearing protective clothing, using a broad-spectrum sunscreen with an SPF of at least 30, avoiding tanning beds, and getting regular skin examinations.

Prognosis is a medical term that refers to the prediction of the likely outcome or course of a disease, including the chances of recovery or recurrence, based on the patient's symptoms, medical history, physical examination, and diagnostic tests. It is an important aspect of clinical decision-making and patient communication, as it helps doctors and patients make informed decisions about treatment options, set realistic expectations, and plan for future care.

Prognosis can be expressed in various ways, such as percentages, categories (e.g., good, fair, poor), or survival rates, depending on the nature of the disease and the available evidence. However, it is important to note that prognosis is not an exact science and may vary depending on individual factors, such as age, overall health status, and response to treatment. Therefore, it should be used as a guide rather than a definitive forecast.

C57BL/6 (C57 Black 6) is an inbred strain of laboratory mouse that is widely used in biomedical research. The term "inbred" refers to a strain of animals where matings have been carried out between siblings or other closely related individuals for many generations, resulting in a population that is highly homozygous at most genetic loci.

The C57BL/6 strain was established in 1920 by crossing a female mouse from the dilute brown (DBA) strain with a male mouse from the black strain. The resulting offspring were then interbred for many generations to create the inbred C57BL/6 strain.

C57BL/6 mice are known for their robust health, longevity, and ease of handling, making them a popular choice for researchers. They have been used in a wide range of biomedical research areas, including studies of cancer, immunology, neuroscience, cardiovascular disease, and metabolism.

One of the most notable features of the C57BL/6 strain is its sensitivity to certain genetic modifications, such as the introduction of mutations that lead to obesity or impaired glucose tolerance. This has made it a valuable tool for studying the genetic basis of complex diseases and traits.

Overall, the C57BL/6 inbred mouse strain is an important model organism in biomedical research, providing a valuable resource for understanding the genetic and molecular mechanisms underlying human health and disease.

Transcription factors are proteins that play a crucial role in regulating gene expression by controlling the transcription of DNA to messenger RNA (mRNA). They function by binding to specific DNA sequences, known as response elements, located in the promoter region or enhancer regions of target genes. This binding can either activate or repress the initiation of transcription, depending on the properties and interactions of the particular transcription factor. Transcription factors often act as part of a complex network of regulatory proteins that determine the precise spatiotemporal patterns of gene expression during development, differentiation, and homeostasis in an organism.

Trans-activators are proteins that increase the transcriptional activity of a gene or a set of genes. They do this by binding to specific DNA sequences and interacting with the transcription machinery, thereby enhancing the recruitment and assembly of the complexes needed for transcription. In some cases, trans-activators can also modulate the chromatin structure to make the template more accessible to the transcription machinery.

In the context of HIV (Human Immunodeficiency Virus) infection, the term "trans-activator" is often used specifically to refer to the Tat protein. The Tat protein is a viral regulatory protein that plays a critical role in the replication of HIV by activating the transcription of the viral genome. It does this by binding to a specific RNA structure called the Trans-Activation Response Element (TAR) located at the 5' end of all nascent HIV transcripts, and recruiting cellular cofactors that enhance the processivity and efficiency of RNA polymerase II, leading to increased viral gene expression.

Messenger RNA (mRNA) is a type of RNA (ribonucleic acid) that carries genetic information copied from DNA in the form of a series of three-base code "words," each of which specifies a particular amino acid. This information is used by the cell's machinery to construct proteins, a process known as translation. After being transcribed from DNA, mRNA travels out of the nucleus to the ribosomes in the cytoplasm where protein synthesis occurs. Once the protein has been synthesized, the mRNA may be degraded and recycled. Post-transcriptional modifications can also occur to mRNA, such as alternative splicing and addition of a 5' cap and a poly(A) tail, which can affect its stability, localization, and translation efficiency.

Homeodomain proteins are a group of transcription factors that play crucial roles in the development and differentiation of cells in animals and plants. They are characterized by the presence of a highly conserved DNA-binding domain called the homeodomain, which is typically about 60 amino acids long. The homeodomain consists of three helices, with the third helix responsible for recognizing and binding to specific DNA sequences.

Homeodomain proteins are involved in regulating gene expression during embryonic development, tissue maintenance, and organismal growth. They can act as activators or repressors of transcription, depending on the context and the presence of cofactors. Mutations in homeodomain proteins have been associated with various human diseases, including cancer, congenital abnormalities, and neurological disorders.

Some examples of homeodomain proteins include PAX6, which is essential for eye development, HOX genes, which are involved in body patterning, and NANOG, which plays a role in maintaining pluripotency in stem cells.

Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is a laboratory technique used in molecular biology to amplify and detect specific DNA sequences. This technique is particularly useful for the detection and quantification of RNA viruses, as well as for the analysis of gene expression.

The process involves two main steps: reverse transcription and polymerase chain reaction (PCR). In the first step, reverse transcriptase enzyme is used to convert RNA into complementary DNA (cDNA) by reading the template provided by the RNA molecule. This cDNA then serves as a template for the PCR amplification step.

In the second step, the PCR reaction uses two primers that flank the target DNA sequence and a thermostable polymerase enzyme to repeatedly copy the targeted cDNA sequence. The reaction mixture is heated and cooled in cycles, allowing the primers to anneal to the template, and the polymerase to extend the new strand. This results in exponential amplification of the target DNA sequence, making it possible to detect even small amounts of RNA or cDNA.

RT-PCR is a sensitive and specific technique that has many applications in medical research and diagnostics, including the detection of viruses such as HIV, hepatitis C virus, and SARS-CoV-2 (the virus that causes COVID-19). It can also be used to study gene expression, identify genetic mutations, and diagnose genetic disorders.

Western blotting is a laboratory technique used in molecular biology to detect and quantify specific proteins in a mixture of many different proteins. This technique is commonly used to confirm the expression of a protein of interest, determine its size, and investigate its post-translational modifications. The name "Western" blotting distinguishes this technique from Southern blotting (for DNA) and Northern blotting (for RNA).

The Western blotting procedure involves several steps:

1. Protein extraction: The sample containing the proteins of interest is first extracted, often by breaking open cells or tissues and using a buffer to extract the proteins.
2. Separation of proteins by electrophoresis: The extracted proteins are then separated based on their size by loading them onto a polyacrylamide gel and running an electric current through the gel (a process called sodium dodecyl sulfate-polyacrylamide gel electrophoresis or SDS-PAGE). This separates the proteins according to their molecular weight, with smaller proteins migrating faster than larger ones.
3. Transfer of proteins to a membrane: After separation, the proteins are transferred from the gel onto a nitrocellulose or polyvinylidene fluoride (PVDF) membrane using an electric current in a process called blotting. This creates a replica of the protein pattern on the gel but now immobilized on the membrane for further analysis.
4. Blocking: The membrane is then blocked with a blocking agent, such as non-fat dry milk or bovine serum albumin (BSA), to prevent non-specific binding of antibodies in subsequent steps.
5. Primary antibody incubation: A primary antibody that specifically recognizes the protein of interest is added and allowed to bind to its target protein on the membrane. This step may be performed at room temperature or 4°C overnight, depending on the antibody's properties.
6. Washing: The membrane is washed with a buffer to remove unbound primary antibodies.
7. Secondary antibody incubation: A secondary antibody that recognizes the primary antibody (often coupled to an enzyme or fluorophore) is added and allowed to bind to the primary antibody. This step may involve using a horseradish peroxidase (HRP)-conjugated or alkaline phosphatase (AP)-conjugated secondary antibody, depending on the detection method used later.
8. Washing: The membrane is washed again to remove unbound secondary antibodies.
9. Detection: A detection reagent is added to visualize the protein of interest by detecting the signal generated from the enzyme-conjugated or fluorophore-conjugated secondary antibody. This can be done using chemiluminescent, colorimetric, or fluorescent methods.
10. Analysis: The resulting image is analyzed to determine the presence and quantity of the protein of interest in the sample.

Western blotting is a powerful technique for identifying and quantifying specific proteins within complex mixtures. It can be used to study protein expression, post-translational modifications, protein-protein interactions, and more. However, it requires careful optimization and validation to ensure accurate and reproducible results.

Spontaneous neoplasm regression is a rare and somewhat controversial phenomenon in which a tumor or malignancy appears to decrease in size or disappear without any treatment or with treatment that is typically not expected to produce such an effect. This can occur through various mechanisms, including immune-mediated processes, apoptosis (programmed cell death), differentiation of cancer cells into normal cells, and angiogenesis inhibition (preventing the growth of new blood vessels that feed the tumor).

Spontaneous regression of neoplasms is not well understood and is considered unpredictable. It has been reported in various types of cancers, including neuroblastoma, melanoma, renal cell carcinoma, and others. However, it should be noted that spontaneous regression does not imply a cure, as the tumor may still recur or metastasize later on.

In summary, spontaneous neoplasm regression refers to the partial or complete disappearance of a malignancy without any specific treatment or with treatment that is not typically associated with such an effect.

Cell division is the process by which a single eukaryotic cell (a cell with a true nucleus) divides into two identical daughter cells. This complex process involves several stages, including replication of DNA, separation of chromosomes, and division of the cytoplasm. There are two main types of cell division: mitosis and meiosis.

Mitosis is the type of cell division that results in two genetically identical daughter cells. It is a fundamental process for growth, development, and tissue repair in multicellular organisms. The stages of mitosis include prophase, prometaphase, metaphase, anaphase, and telophase, followed by cytokinesis, which divides the cytoplasm.

Meiosis, on the other hand, is a type of cell division that occurs in the gonads (ovaries and testes) during the production of gametes (sex cells). Meiosis results in four genetically unique daughter cells, each with half the number of chromosomes as the parent cell. This process is essential for sexual reproduction and genetic diversity. The stages of meiosis include meiosis I and meiosis II, which are further divided into prophase, prometaphase, metaphase, anaphase, and telophase.

In summary, cell division is the process by which a single cell divides into two daughter cells, either through mitosis or meiosis. This process is critical for growth, development, tissue repair, and sexual reproduction in multicellular organisms.

Gene expression profiling is a laboratory technique used to measure the activity (expression) of thousands of genes at once. This technique allows researchers and clinicians to identify which genes are turned on or off in a particular cell, tissue, or organism under specific conditions, such as during health, disease, development, or in response to various treatments.

The process typically involves isolating RNA from the cells or tissues of interest, converting it into complementary DNA (cDNA), and then using microarray or high-throughput sequencing technologies to determine which genes are expressed and at what levels. The resulting data can be used to identify patterns of gene expression that are associated with specific biological states or processes, providing valuable insights into the underlying molecular mechanisms of diseases and potential targets for therapeutic intervention.

In recent years, gene expression profiling has become an essential tool in various fields, including cancer research, drug discovery, and personalized medicine, where it is used to identify biomarkers of disease, predict patient outcomes, and guide treatment decisions.

... (HGPIN) is an abnormality of prostatic glands and believed to precede the ... "Contemporary clinical management of isolated high-grade prostatic intraepithelial neoplasia". Prostate Cancer Prostatic Dis. 11 ... Bostwick DG, Qian J (March 2004). "High-grade prostatic intraepithelial neoplasia". Mod. Pathol. 17 (3): 360-79. doi:10.1038/ ... Ayala, AG; Ro, JY (August 2007). "Prostatic intraepithelial neoplasia: recent advances". Archives of Pathology & Laboratory ...
... prostatic tissue (NNT). B. Benign prostatic hyperplasia. C. High-grade prostatic intraepithelial neoplasia. D. Prostatic ... "A Systematic Review of Prostatic Artery Embolization in the Treatment of Symptomatic Benign Prostatic Hyperplasia". ... Prostatic urethral lift (marketed as UroLift): This intervention consists of a system of a device and an implant designed to ... Benign prostatic hyperplasia and prostate cancer are both capable of increasing blood PSA levels and PSA elevation is unable to ...
... these mice develop prostatic intraepithelial neoplasia (PINs). Ack1 has emerged as a new cancer target and multiple small ...
... they form a small clump of disregulated cells called a prostatic intraepithelial neoplasia (PIN). Some PINs continue to grow, ... Prostatic Intraepithelial Neoplasia (PIN) and Intraductal Carcinoma". American Cancer Society. Retrieved 25 May 2023. Rebello ... Hardening of the prostate can also be due to benign prostatic hyperplasia; around 20-25% of those with abnormal findings on ... March 1982). "Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone ...
A urine diagnostic marker for prostatic intraepithelial neoplasia". Clinical Cancer Research. 13 (3): 929-38. doi:10.1158/1078- ...
High-grade prostatic intraepithelial neoplasia is equivalent to CIS of the prostate. Bronchioloalveolar carcinoma (BAC) of the ... Cervical squamous intraepithelial lesion (SIL), previously called cervical intraepithelial neoplasia (CIN), is a form of ...
... this is higher than if there is high-grade prostatic intraepithelial neoplasia (HGPIN). ASAP is considered an indication for re ... In urologic pathology, atypical small acinar proliferation, is a collection of small prostatic glands, on prostate biopsy, ...
Mitoses (also seen in for example high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate inflammation). Prominent ... Zhou, Ming (2018). "High-grade prostatic intraepithelial neoplasia, PIN-like carcinoma, ductal carcinoma, and intraductal ... "Prostatic Adenocarcinoma". Stanford Medical School. Last update 2/2/16 Li J, Wang Z (February 2016). "The pathology of unusual ... Liu T, Wang Y, Zhou R, Li H, Cheng H, Zhang J (February 2016). "The update of prostatic ductal adenocarcinoma". Chin. J. Cancer ...
2000). "Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer". ...
Its expression was also associated with a higher proliferative index in prostatic intraepithelial neoplasia and cancer. Human ... "Minichromosome maintenance complex component 7 has an important role in the invasion of papillary urothelial neoplasia". ... papillary urothelial neoplasia, esophageal cancer, and endometrial cancer. ...
LOH has been reported to be observed in 12-89% of high-grade prostatic intraepithelial neoplasia (PIN) and 35-86% of prostatic ... Loss of NKX3A protein expression is a common finding in human prostate carcinomas and prostatic intraepithelial neoplasia. In ... The researchers suggested that the NKX3-1 gene plays a role in androgen-driven differentiation of prostatic tissue as well as ... Loss of function of NKX3-1 leads to defects in prostatic protein secretions as well as ductal morphogenesis. Loss of function ...
Subjects had a median age of 64 years and were diagnosed with high-grade prostatic intraepithelial neoplasia (HGPIN), which is ... Thompson Jr, I. M., and Leach, R., Prostate cancer and prostatic intraepithelial neoplasia: true, true, and unrelated? J Clin ... III clinical trial for the prevention of prostate cancer in high risk men with high grade prostatic intraepithelial neoplasia, ... Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase ...
1997). "Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel ... Prostatic acid phosphatase (PAP), also prostatic specific acid phosphatase (PSAP), is an enzyme produced by the prostate. It ... Nguyen L, Chapdelaine A, Chevalier S (1990). "Prostatic acid phosphatase in serum of patients with prostatic cancer is a ... Warhol MJ, Longtine JA (1985). "The ultrastructural localization of prostatic specific antigen and prostatic acid phosphatase ...
... and in high-grade prostatic intraepithelial neoplasia (HGPIN), and that the murine orthologue is increased in SV40-based ... "Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP ... mouse model". Neoplasia. 8 (6): 510-22. doi:10.1593/neo.06202. PMC 1601466. PMID 16820097. Kelavkar UP, Badr KF (1999). " ...
"Conditional Expression of Human 15-Lipoxygenase-1 in Mouse Prostate Induces Prostatic Intraepithelial Neoplasia: The FLiMP ... Neoplasia. 11 (7): 692-9. doi:10.1593/neo.09334. PMC 2697355. PMID 19568414. Edwards, I. J; Berquin, I. M; Sun, H; O'Flaherty, ... Neoplasia. 6 (1): 41-52. doi:10.1016/S1476-5586(04)80052-6. PMC 1508629. PMID 15068670. Kelavkar, Uddhav P; Parwani, Anil V; ... Journal of Mammary Gland Biology and Neoplasia. 16 (3): 235-45. doi:10.1007/s10911-011-9222-4. PMID 21773809. S2CID 22711432. ...
... cervical intraepithelial neoplasia MeSH C04.557.470.200.240.500 - prostatic intraepithelial neoplasia MeSH C04.557.470.200.255 ... multiple endocrine neoplasia type 2a MeSH C04.651.600.510 - multiple endocrine neoplasia type 2b MeSH C04.697.152.110 - blast ... multiple endocrine neoplasia type 2a MeSH C04.700.630.510 - multiple endocrine neoplasia type 2b MeSH C04.700.635.220 - denys- ... multiple endocrine neoplasia type 1 MeSH C04.588.322.400.505 - multiple endocrine neoplasia type 2a MeSH C04.588.322.400.510 - ...
... a unique chemical name Prostatic intraepithelial neoplasia (PIN), an abnormality of prostatic glands Pin (amateur wrestling), a ...
... grade III Prostatic intraepithelial neoplasia, grade III (C61.9) PIN III M8149/0 Canalicular adenoma M8150/0 Islet cell adenoma ... Vulvar intraepithelial neoplasia, grade III (C51._) VIN III (C51._) Anal intraepithelial neoplasia, grade III (C21.1) AIN III ( ... microinvasive M8077/2 Squamous intraepithelial neoplasia, grade III Cervical intraepithelial neoplasia, grade III (C53._) CIN ... NOS Ductal intraepithelial neoplasia 3 DIN 3 M8500/3 Infiltrating duct carcinoma, NOS (C50._) Infiltrating duct adenocarcinoma ...
... prostatic acid phosphatase - prostatic intraepithelial neoplasia - prostatitis - protease inhibitor - protein kinase C - ... cervical intraepithelial neoplasia - cervix - cetuximab - cevimeline - CGP 48664 - Chamberlain procedure - chemoembolization - ... Endometrial intraepithelial neoplasia - endometriosis - endometrium - endorectal ultrasound - endoscope - endoscopic retrograde ... multiple endocrine neoplasia syndrome - multiple endocrine neoplasia type 1 syndrome - multiple myeloma - multiple sclerosis - ...
... of ovary labor Lichen simplex chronicus Lichen sclerosus Lichen planus miscarriage imperforate hymen intraepithelial neoplasia ... vulva tumor vaginal bleeding vaginoplasty vulvar vestibulitis vulvar skin cracks and bleeds vulvectomy benign prostatic ...
"Increased expression of prostate-specific G-protein-coupled receptor in human prostate intraepithelial neoplasia and prostate ... 2006). "Quantitative expression profile of PSGR in prostate cancer". Prostate Cancer and Prostatic Diseases. 9 (1): 56-61. doi: ...
Overexpression of FGF9 in prostate epithelial cells can lead to high grade prostate intraepithelial neoplasia, which is a ... Giri D, Ropiquet F, Ittmann M (July 1999). "FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic ... "Promatrilysin expression is induced by fibroblast growth factors in the prostatic carcinoma cell line LNCaP but not in normal ...
Human neoplasias, including thyroid, prostatic, cervical, colorectal, pancreatic and ovarian carcinoma, show a strong increase ... cervix intraepithelial neoplasia (CIN) is primarily caused by oncogenic HPV16. As in many cases, the causative factor for ... the direct route from infection to cancer is sometimes detoured to a precancerous state in cervix intraepithelial neoplasia. ...
High-grade prostatic intraepithelial neoplasia (HGPIN) is an abnormality of prostatic glands and believed to precede the ... "Contemporary clinical management of isolated high-grade prostatic intraepithelial neoplasia". Prostate Cancer Prostatic Dis. 11 ... Bostwick DG, Qian J (March 2004). "High-grade prostatic intraepithelial neoplasia". Mod. Pathol. 17 (3): 360-79. doi:10.1038/ ... Ayala, AG; Ro, JY (August 2007). "Prostatic intraepithelial neoplasia: recent advances". Archives of Pathology & Laboratory ...
High-grade prostatic intraepithelial neoplasia (PIN) is now accepted as the most likely preinvasive stage of adenocarcinoma, a ... Prostatic intraepithelial neoplasia is a risk factor for cancer Semin Urol Oncol. 1999 Nov;17(4):187-98. ... High-grade prostatic intraepithelial neoplasia (PIN) is now accepted as the most likely preinvasive stage of adenocarcinoma, a ... Prostatic Intraepithelial Neoplasia / blood * Prostatic Intraepithelial Neoplasia / epidemiology * Prostatic Intraepithelial ...
Inflammation, focal prostatic atrophy, and prostatic intraepithelial neoplasia (PIN) are common in prostate tumor specimens, ... Inflammation, Focal Atrophic Lesions, and Prostatic Intraepithelial Neoplasia with Respect to Risk of Lethal Prostate Cancer ... Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization ... Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia ...
Prostatic intraepithelial neoplasia. Prostatic intraepithelial neoplasia (PIN) represents the putative precancerous end of the ... Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer. J Urol. 2010 Nov. ... Bostwick DG, Qian J. High-grade prostatic intraepithelial neoplasia. Mod Pathol. 2004 Mar. 17(3):360-79. [QxMD MEDLINE Link]. ... High-grade prostatic intraepithelial neoplasia (HGPIN) at ≥3 biopsy sites (~30% risk) ...
MR led to significant reductions in the development of Prostatic Intraepithelial Neoplasia (PIN) lesions, specifically in the ... Dietary methionine restriction inhibits prostatic intraepithelial neoplasia in TRAMP mice. Dec 1, 2014 , Publications ...
Diagnostic utility of antibody cocktail expression in differentiating prostatic intraepithelial neoplasia with carcinoma. ... Objectives Histopathologists often face difficulties in diagnosing Prostatic Intraepithelial Neoplasia (PIN) or borderline ... It has potential to be considered as screening immunohistochemical module for reporting of prostatic biopsies. ... of multiplex antibody cocktail mixtures comprising of neoplastic acinar as well as basal cell markers for demarcating prostatic ...
T1 - Prostatic intraepithelial neoplasia. T2 - Significance and correlation with prostate-specific antigen and transrectal ... Prostatic intraepithelial neoplasia: Significance and correlation with prostate-specific antigen and transrectal ultrasound: ... Prostatic intraepithelial neoplasia: Significance and correlation with prostate-specific antigen and transrectal ultrasound: ... Prostatic intraepithelial neoplasia: Significance and correlation with prostate-specific antigen and transrectal ultrasound: ...
What is PIN? (Prostatic Intraepithelial Neoplasia). If your doctor has diagnosed you with prostatic intraepithelial neoplasia ( ... Read More What is PIN? (Prostatic Intraepithelial Neoplasia). ...
20 of low grade prostatic intraepithelial neoplasia (PIN), 20 of high grade PIN, 20 of prostatic adenocarcinoma with a ... Case diagnosis as positive identification in prostatic neoplasia Anal Quant Cytol Histol. 1998 Oct;20(5):424-36. ... Prostatic Intraepithelial Neoplasia / classification * Prostatic Intraepithelial Neoplasia / pathology* * Prostatic Neoplasms ... measure and Bayesian belief network-based methodology to the positive identification of case diagnosis in prostatic neoplasia. ...
the biopsy showed high-grade prostatic intra-epithelial neoplasia (HGPIN). * the biopsy showed atypical small acinar ... Do not offer biopsy of the prostatic bed to people with prostate cancer who have had a radical prostatectomy. [2008] ...
High Grade Prostatic Intraepithelial Neoplasia.. Note: The positive surgical margins are in an area of extra prostatice ... Left apical tissue - benign prostatic tissue only. Right apical tissue-prostatic acinar adenocarcinoma , Gleason score 4+3=7 ... Extensive Extra Prostatic Extension is Identified Involving the Right Apex, The Right and Left Mid, And The Right Base. -The ... Location Main Tumor: Prostatic Base. Location Additional Tumor Nodules: Left Apex, Right Apex, Right Mid, Left Mid, and Left ...
Thompson IM, Lucia MS, Redman MW, et al.: Finasteride decreases the risk of prostatic intraepithelial neoplasia. J Urol 178 (1 ... Nelson PS, Gleason TP, Brawer MK: Chemoprevention for prostatic intraepithelial neoplasia. Eur Urol 30 (2): 269-78, 1996. ... Sakr WA, Haas GP, Cassin BF, et al.: The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male ... outcomes of the PCPT found that finasteride significantly reduced the risk of high-grade prostatic intraepithelial neoplasia ( ...
Hypoxia-mediated stabilization of HIF1A in prostatic intraepithelial neoplasia promotes cell plasticity and malignant ... Hypoxia-mediated stabilization of HIF1A in prostatic intraepithelial neoplasia promotes cell plasticity and malignant ... Single-cell analyses unravel cell type-specific responses to a vitamin D analog in prostatic precancerous lesions. * Mohamed ...
Hypoxia-mediated stabilization of HIF1A in prostatic intraepithelial neoplasia promotes cell plasticity and malignant ... Single-cell analyses unravel cell type-specific responses to a vitamin D analog in prostatic precancerous lesions. * Mohamed ...
High grade prostatic intraepithelial neoplasia (HGPIN). G) Prostate, lesion 1 left apex, core biopsy:. - Prostatic ... In a 3T MRI it did show up but no extra prostatic extension!!!. ...
... high-grade prostatic intraepithelial neoplasia (HGPIN) and some others. b Study design includes validation of the AI tool using ... High-grade prostatic intraepithelial neoplasia (HGPIN) lesions were classified as benign, although the algorithm recognizes ... high-grade prostatic intraepithelial neoplasia with adjacent atypical glands-conditions with high interobserver variability and ...
Molecular Pathology of High-Grade Prostatic Intraepithelial Neoplasia: Challenges and Opportunities. Levent Trabzonlu, Ibrahim ...
Isolated prostatic intraepithelial neoplasia and positive cancer results at repeat biopsy: Our series review. Arzoz Fábregas, M ... Analisis of the scientific evidence of the combination therapy in benign prostatic hyperplasia. Millán Rodríguez, F.. · ...
High-level expression of EphA2 receptor tyrosine kinase in prostatic intraepithelial neoplasia. Am J Pathol. 2003;163:2271-6 ...
Epidemiology of high grade prostatic intraepithelial neoplasia. Pathol Res Pract. 1995 Sep;191(9):838-41. ... 8. PAP (Prostatic Acid Phosphatase) Test The PAP test is a simple blood test, used to measure the amount of an enzyme-called ... Prostate Cancer Prostatic Dis. 2010 Dec;13(4):343-9. *Dorai T, Cao YC, Dorai B, Buttyan R, Katz AE. Therapeutic potential of ... Prostatic fluids from patients with cancer also have higher prolactin levels than controls. 17 In vitro, prolactin induces ...
Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. ... 68Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for ... Comparison of prostate specific membrane antigen, and prostate specific antigen levels in prostatic cancer patients. Anticancer ... 68Ga-PSMA ligand PET/CT reveals focal uptake in left paramedian prostatic fossa, indicating local recurrence. Shown are ...
BJUI Mini Reviews - Prostatic intraepithelial neoplasia: Its morphological and molecular diagnosis and clinical significance ...
Transgenic overexpression of FOXP2 in the mouse prostate causes prostatic intraepithelial neoplasia. Overexpression of FOXP2 ... but its expression is absent in normal prostate epithelial cells and low in benign prostatic hyperplasia. FOXP2 is a FOX ...
"Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer," Cancer, ... B. Gurel, T. Z. Ali, E. A. Montgomery et al., "NKX3.1 as a marker of prostatic origin in metastatic tumors," The American ... G. Pace, C. Di Massimo, D. De Amicis et al., "Oxidative stress in benign prostatic hyperplasia and prostate cancer," Urologia ... A. M. Baker, L. W. Oberley, and M. B. Cohen, "Expression of antioxidant enzymes in human prostatic adenocarcinoma," The ...
Elevated expression of the colony-stimulating factor 1 (CSF1) induces prostatic intraepithelial neoplasia dependent of ...
Prostatic intraepithelial neoplasia without evidence of prostate cancer.. * Adequately treated urothelial papillary noninvasive ...
Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer ... stromal and intraepithelial: r = 0.80, P , 0.0001; stromal and luminal: r = 0.25, P = 0.0003; and intraepithelial and luminal: ... A to C, increasing severity of inflammation in the stroma; D to F, increasing severity of intraepithelial inflammation; G to I ... A to C, increasing severity of inflammation in the stroma; D to F, increasing severity of intraepithelial inflammation; G to I ...
Godoy G, Huang GJ, Patel T, Taneja SS "Long-term follow-up of men with isolated high-grade prostatic intra-epithelial neoplasia ...
Roberts and his team worked with a mouse model of high-grade prostatic intraepithelial neoplasia and used various types of ADT ... An abnormality called "high-grade prostatic intraepithelial neoplasia" is a major precursor for prostate cancer. The condition ... Androgen deprivation therapy may be harmful to men with intraepithelial neoplasia (RxWiki News) Most prostate cancers are fed ... Prostate CancerMenopause Hormone ReplacementBenign Prostatic HyperplasiaLow TestosteroneCancerEndometrial CancerVulvar Cancer ...
  • Limited review of literature reveals high specificity of multiplex antibody cocktail mixtures comprising of neoplastic acinar as well as basal cell markers for demarcating prostatic lesions. (journalcra.com)
  • It stains premalignant lesions of prostate:highgrade prostatic intraepithelial neoplasia ,PIN) and atypical adenomatous hyperplasia. (groundwater-2011.net)
  • High-grade prostatic intraepithelial neoplasia (HGPIN) is an abnormality of prostatic glands and believed to precede the development of prostate adenocarcinoma (the most common form of prostate cancer). (wikipedia.org)
  • Its cytologic features are that of prostatic adenocarcinoma: presence of nucleoli, increased nuclear-to-cytoplasmic ratio and, increased nuclear size. (wikipedia.org)
  • High-grade prostatic intraepithelial neoplasia (PIN) is now accepted as the most likely preinvasive stage of adenocarcinoma, a decade after its first formal description. (nih.gov)
  • Objectives Histopathologists often face difficulties in diagnosing Prostatic Intraepithelial Neoplasia (PIN) or borderline Adenocarcinoma (PAC) cases on the basis of hematoxylin and eosin (H & E) stain alone. (journalcra.com)
  • Eight morphologic and cellular features were analyzed in 20 cases of normal prostate, 20 of low grade prostatic intraepithelial neoplasia (PIN), 20 of high grade PIN, 20 of prostatic adenocarcinoma with a cribriform pattern and 20 of prostatic adenocarcinoma with an acinar pattern. (nih.gov)
  • Expression of AMARC protein is found in prostatic adenocarcinoma but not in benign prostatic tissue. (groundwater-2011.net)
  • This retrospective study aimed to assess the concordance and interobserver variation between histopathologists in reporting prostatic adenocarcinoma using material obtained from prostatic core biopsy specimens. (who.int)
  • A total of 810 prostatic needle core biopsy specimens obtained from 100 patients with suspected prostatic adenocarcinoma were retrieved from the archival material at King Khalid University Hospital, Riyadh, and classified independently by 3 experienced histopathologists who were blinded to the original diagnosis. (who.int)
  • of prostatic adenocarcinoma among 3 Analysis histopathology consultants. (who.int)
  • It is considered to be a pre-malignancy, or carcinoma in situ, of the prostatic glands. (wikipedia.org)
  • An abnormality called "high-grade prostatic intraepithelial neoplasia" is a major precursor for prostate cancer. (rxwiki.com)
  • Purpose To assess how Gleason grade, maximum cancer core length (MCCL), inflammation, prostatic intraepithelial neoplasia (PIN), or atypical small acinar proliferation within a Barzell zone affects the odds of MRI visibility. (bvsalud.org)
  • HGPIN is diagnosed from tissue by a pathologist, which may come from:[citation needed] a needle biopsy taken via the rectum and, surgical removal of prostate tissue: transurethral resection of the prostate - removal of extra prostate tissue to improve urination (a treatment for benign prostatic hyperplasia), radical prostatectomy - complete removal of prostate and seminal vesicles (a treatment for prostate cancer). (wikipedia.org)
  • Management of Benign Prostatic Hyperplasia: Could Dietary Polyphenols Be an Alternative to Existing Therapies? (frontiersin.org)
  • The incidence of benign prostatic hyperplasia (BPH) is gradually on the increase. (frontiersin.org)
  • Benign prostatic hyperplasia (BPH) is the most common urological condition among elderly men, affecting approximately half of men over 80 years of age. (frontiersin.org)
  • [ 7 ] The PSA level also tends to rise in men with benign prostatic hyperplasia (BPH) and is a good marker for prostate volume. (medscape.com)
  • Walsh, PC 1990, ' Prostatic intraepithelial neoplasia: Significance and correlation with prostate-specific antigen and transrectal ultrasound: Editorial comment ', Journal of Urology , vol. 144, no. 4. (johnshopkins.edu)
  • For men, a condition known as high-grade prostatic intraepithelial neoplasia (HGPIN), which is a kind of precursor to cancer, is often mistreated as if it was actually cancer. (davidwolfe.com)
  • However, one recent intervention study conducted in Italy revealed that men with a precursor to prostate cancer called prostatic intraepithelial neoplasia (PIN) who consumed a green tea extract reduced their risk for progression to prostate cancer. (lesliebeck.com)
  • It has potential to be considered as screening immunohistochemical module for reporting of prostatic biopsies. (journalcra.com)
  • The Gleason score (grade rate of prostate cancer in Saudi Arabia 810 prostatic needle biopsies obtained of malignant cases) was not, however, ranked sixth among male patients with from 100 patients from 2005 until the recorded as this parameter was outside a crude annual incidence of 5.7 per end of 2011 were retrieved from the the scope of this retrospective study. (who.int)
  • Prostatic intraepithelial neoplasia is considered a possible premalignant histologic change. (msdmanuals.com)
  • To apply a distance measure and Bayesian belief network-based methodology to the positive identification of case diagnosis in prostatic neoplasia. (nih.gov)
  • Researchers at the Harvard Medical School investigated the effect of androgen deprivation in a preclinical mouse model of stable high grade prostatic intraepithelial neoplasia induced by the loss of the PTEN tumor suppressor. (malecare.org)
  • We showed that there was an increase in angiogenesis (an angiogenic switch), structurally patterned by adrenergic nerves, during progression from the pre-neoplastic low-grade prostatic intraepithelial neoplasia (PIN) to the cancer-committed high-grade PIN," Ali said. (taconic.com)
  • Depleting β-adrenergic receptors (βARs) within the prostatic-stromal sympathetic nervous system (SNS) attenuates tumor growth in mouse models, suggesting a contributing role from the SNS in carcinogenesis. (taconic.com)
  • PIN is associated with progressive abnormalities of phenotype and genotype, which are similar to cancer rather than normal prostatic epithelium, indicating impairment of cell differentiation with advancing stages of prostatic carcinogenesis. (nih.gov)
  • Prostatic intraepithelial neoplasia without evidence of prostate cancer. (iu.edu)
  • For this study, Dr. Roberts and his team worked with a mouse model of high-grade prostatic intraepithelial neoplasia and used various types of ADT to treat it. (rxwiki.com)
  • Tumour involves approximately 20-25% of prostatic volume. (cancer.org)
  • HGPIN is diagnosed from tissue by a pathologist, which may come from:[citation needed] a needle biopsy taken via the rectum and, surgical removal of prostate tissue: transurethral resection of the prostate - removal of extra prostate tissue to improve urination (a treatment for benign prostatic hyperplasia), radical prostatectomy - complete removal of prostate and seminal vesicles (a treatment for prostate cancer). (wikipedia.org)
  • Indeed, even in benign tissue, transverse sections of prostatic ducts are indistinguishable from acini. (bmj.com)
  • Monitor patients with benign prostatic hyperplasia (BPH) for worsening of signs and symptoms of BPH ( 5.3 ). (nih.gov)
  • Physical examination alone cannot reliably differentiate benign prostatic disease from cancer. (medscape.com)
  • Other causes of elevated PSA include benign prostatic hyperplasia (BPH), prostatitis, and recent prostate biopsy or DRE. (uspharmacist.com)
  • This spectrum includes small acinar proliferations suspicious for but not diagnostic of cancer, benign mimics of cancer, the preinvasive entity of high-grade prostatic intraepithelial neoplasia, and various treatment effects. (nih.gov)
  • We tested for the GSTP1 genotype in a population of prostate cancer patients, and in a control group composed of patients with benign prostatic hyperplasia (BPH) and healthy blood donors. (nih.gov)
  • To explore the potential microbiome signature associated with PCa in Indian patients, we investigated differential compositions of commensal bacteria among patients with benign prostatic hyperplasia (BPH) and PCa using 16S rRNA amplicon sequencing followed by qPCR analyses using two distinct primer sets. (researchsquare.com)
  • This is called benign prostatic hyperplasia (BPH). (sarahbush.org)
  • Objectives: To evaluate factors that may predict prostate cancer (PCa) detection after initial diagnosis of high-grade prostatic intraepithelial neoplasia (HGPIN) on 6-24 cores prostatic biopsies (PBx). (uninsubria.it)
  • This week, a National Cancer Institute commissioned panel's report published in JAMA online confirmed that we all - public and professionals alike - should stop calling low-risk lesions like DCIS and high-grade prostatic intraepithelial neoplasia (HGPIN) 'cancer. (wakeup-world.com)
  • We introduce a label-free method for detecting high-grade prostatic intraepithelial neoplasia (HGPIN) in unstained biopsies. (phioptics.com)
  • It is considered to be a pre-malignancy, or carcinoma in situ, of the prostatic glands. (wikipedia.org)
  • Perhaps most dramatically, the group says that a number of premalignant conditions, including ductal carcinoma in situ and high-grade prostatic intraepithelial neoplasia, should no longer be called "cancer. (wakeup-world.com)
  • Adding to the complexity is the lack of distinct histological differences between prostatic ducts and acini. (bmj.com)
  • 1 The peri-urethral ducts give off branches, with tributaries adopting the epithelial morphology of prostatic acini as they progress upstream from the urethra (fig 1). (bmj.com)
  • The tall columnar cells lining the larger ducts resemble the cells lining the smaller ducts and acini in their staining patterns with prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP). (bmj.com)
  • Distinction from prostatic adenoma is based largely on compression of contiguous acini by an expanding and relatively discrete epithelial proliferation filling acini. (nih.gov)
  • Antonov A.G., Gordeev V.V. Prostatic high-grade intraepithelial neoplasia as a tissue marker for prostate cancer detection. (pmarchive.ru)
  • In some experimental models, androgen deprivation results in a spontaneous increase in estrogen receptor (ER) expression in prostatic tissue. (nih.gov)
  • Recent studies showed that 30% of men with high-grade prostate intraepithelial neoplasia (HG-PIN) would develop prostate cancer (CaP) within 1 year after repeated biopsy. (aacrjournals.org)
  • This phytochemical has been shown to inhibit the growth of LNCaP human prostatic cancer cells in culture (IC50 = 50 ?M). It also has been shown to reduce one of the most fundamental biomarkers for prostate cancer, PSA, as well as modulate other proliferation and cell cycle related factors including PCNA, p21 (WAF1) and p27 (Kip1). (nih.gov)
  • Dr. Nelson's laboratory has discovered the most common known somatic genome alteration in human prostatic carcinoma cells. (hopkinsmedicine.org)
  • Although immunotherapy with the Food and Drug Administration‐approved vaccine sipuleucel‐T, which targets prostatic acid phosphatase (PAP), extends survival for 2-4 months, the identification of new immunogenic tumor-associated antigens (TAAs) continues to be an unmet need. (bmj.com)
  • We sought to a ) reassess whether a range of BPA exposures drives prostate pathology and/or alters prostatic susceptibility to hormonal carcinogenesis, and b ) test whether chronic low-dose BPA targets prostate epithelial stem and progenitor cells. (nih.gov)
  • 6. Endpoint markers for clinical trials of chemopreventive agents derived from the properties of epithelial precancer (intraepithelial neoplasia) measured by computer-assisted image analysis. (nih.gov)
  • PIN is associated with progressive abnormalities of phenotype and genotype, which are similar to cancer rather than normal prostatic epithelium, indicating impairment of cell differentiation with advancing stages of prostatic carcinogenesis. (nih.gov)
  • Pathogen including oncogenic viruses and bacterial infections are thought to play critical role in prostatic inflammation 9 . (researchsquare.com)
  • Nevertheless, a growing body of evidence suggests that a number of bacterial species including E. coli and other species of Enterobacteriaceae can promote prostatic inflammation 3 , 10 . (researchsquare.com)
  • In addition, sexually transmitted infections with Chlamydia trachomatis , Neisseria gonorrhoeae and Trichomonas vaginalis are also shown to increase prostatic inflammation, which in turn elevate serum PSA levels 11 , 12 . (researchsquare.com)
  • The pro-inflammatory Propionibacterium species, in particular P. acnes associated with human skin, has been well studied in connection to PCa development, and has also been found to induce prostatic inflammation in animal models 13 - 16 . (researchsquare.com)
  • 3. Properties of intraepithelial neoplasia relevant to cancer chemoprevention and to the development of surrogate end points for clinical trials. (nih.gov)
  • 4. Intraepithelial neoplasia, surrogate endpoint biomarkers, and cancer chemoprevention. (nih.gov)
  • 5. Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy. (nih.gov)
  • Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance. (nih.gov)
  • The neoplasia takes the form of an intra-acinar or ductal proliferation of secretory cells with unequivocal nuclear anaplasia, which corresponds to nuclear grade 2 and 3 invasive prostate cancer. (uams.edu)
  • 12. The natural history of intraepithelial neoplasia: relevance to the search for intermediate endpoint biomarkers. (nih.gov)
  • 20. Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. (nih.gov)
  • Each of the three anatomically distinct zones of the prostate has its own set of periurethral main prostatic ducts lined by several layers of urothelial-like cells, reminiscent of the urothelium. (bmj.com)
  • The DNA lesion-hypermethylation of deoxycytidine nucleotides in the promoter of a carcinogen-defense enzyme gene-appears to inactivate the gene, making prostatic cells more vulnerable to carcinogens. (hopkinsmedicine.org)
  • The lack of a similar gene in mouse results in growth retardation, severe spinal curvature, subfertility, premature aging, and prostatic intraepithelial neoplasia (PIN) development. (origene.com)
  • One type of abnormal growth is called prostatic intraepithelial neoplasia or PIN. (sarahbush.org)
  • In one study, ate a low-fat diet with 30 grams of flaxseed daily lowered prostate specific antigen levels (a marker of prostate health) in men with a precancerous prostate condition called prostatic intraepithelial neoplasia. (usda.gov)
  • 1. Intraepithelial and postinvasive neoplasia as a stochastic continuum of clonal evolution, and its relationship to mechanisms of chemopreventive drug action. (nih.gov)
  • This graph shows the total number of publications written about "Prostatic Intraepithelial Neoplasia" by people in UAMS Profiles by year, and whether "Prostatic Intraepithelial Neoplasia" was a major or minor topic of these publications. (uams.edu)
  • Zavalishina L.E., Kekeeva T.V., Frank G.A. Prostatic intraepithelial neoplasia of high degree: the current state of the problem. (pmarchive.ru)